% $ biblatex auxiliary file $
% $ biblatex bbl format version 3.0 $
% Do not modify the above lines!
%
% This is an auxiliary file used by the 'biblatex' package.
% This file may safely be deleted. It will be recreated by
% biber as required.
%
\begingroup
\makeatletter
\@ifundefined{ver@biblatex.sty}
  {\@latex@error
     {Missing 'biblatex' package}
     {The bibliography requires the 'biblatex' package.}
      \aftergroup\endinput}
  {}
\endgroup


\refsection{0}
  \datalist[entry]{nty/global//global/global}
    \entry{morb_toprak}{article}{}
      \name{author}{1}{}{%
        {{hash=82b7edbc9f0e3cd6bab6b67c3a1539f0}{%
           family={al.},
           familyi={a\bibinitperiod},
           given={Erdal\bibnamedelima Toprak},
           giveni={E\bibinitperiod\bibinitdelim T\bibinitperiod},
           prefix={et},
           prefixi={e\bibinitperiod}}}%
      }
      \strng{namehash}{82b7edbc9f0e3cd6bab6b67c3a1539f0}
      \strng{fullhash}{82b7edbc9f0e3cd6bab6b67c3a1539f0}
      \strng{bibnamehash}{82b7edbc9f0e3cd6bab6b67c3a1539f0}
      \strng{authorbibnamehash}{82b7edbc9f0e3cd6bab6b67c3a1539f0}
      \strng{authornamehash}{82b7edbc9f0e3cd6bab6b67c3a1539f0}
      \strng{authorfullhash}{82b7edbc9f0e3cd6bab6b67c3a1539f0}
      \field{extraname}{1}
      \field{sortinit}{a}
      \field{sortinithash}{d77c7cdd82ff690d4c3ef13216f92f0b}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{journaltitle}{PMC}
      \field{title}{Building a Morbidostat: An automated continuous-culture device for studying bacterial drug resistance under dyna-ally sustained drug inhibition}
      \field{year}{2013}
    \endentry
    \entry{nanopore}{article}{}
      \name{author}{1}{}{%
        {{hash=742e43262369f1a81db09212088c666a}{%
           family={al.},
           familyi={a\bibinitperiod},
           given={Nicholas\bibnamedelima Noll},
           giveni={N\bibinitperiod\bibinitdelim N\bibinitperiod},
           prefix={et},
           prefixi={e\bibinitperiod}}}%
      }
      \strng{namehash}{742e43262369f1a81db09212088c666a}
      \strng{fullhash}{742e43262369f1a81db09212088c666a}
      \strng{bibnamehash}{742e43262369f1a81db09212088c666a}
      \strng{authorbibnamehash}{742e43262369f1a81db09212088c666a}
      \strng{authornamehash}{742e43262369f1a81db09212088c666a}
      \strng{authorfullhash}{742e43262369f1a81db09212088c666a}
      \field{extraname}{2}
      \field{sortinit}{a}
      \field{sortinithash}{d77c7cdd82ff690d4c3ef13216f92f0b}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{journaltitle}{bioarchive}
      \field{title}{Prokka: Resolving structural diversity of Carbapenemase-producing gram-negative bacteria using single molecule sequencing}
      \field{year}{2018}
    \endentry
    \entry{swiss_hospitals_pathogens}{online}{}
      \field{sortinit}{A}
      \field{sortinithash}{d77c7cdd82ff690d4c3ef13216f92f0b}
      \field{labeltitlesource}{title}
      \field{day}{27}
      \field{month}{3}
      \field{title}{Antibiotikaresistenzen}
      \field{year}{2019}
      \field{dateera}{ce}
      \verb{urlraw}
      \verb https://www.bag.admin.ch/bag/de/home/krankheiten/infektionskrankheiten-bekaempfen/antibiotikaresistenzen/welche-bakteriellen-krankheiten-gibt-es-.html
      \endverb
      \verb{url}
      \verb https://www.bag.admin.ch/bag/de/home/krankheiten/infektionskrankheiten-bekaempfen/antibiotikaresistenzen/welche-bakteriellen-krankheiten-gibt-es-.html
      \endverb
    \endentry
    \entry{swiss_hospitals}{online}{}
      \field{sortinit}{A}
      \field{sortinithash}{d77c7cdd82ff690d4c3ef13216f92f0b}
      \field{labeltitlesource}{title}
      \field{day}{27}
      \field{month}{3}
      \field{title}{Antibiotikaresistenzen}
      \field{year}{2019}
      \field{dateera}{ce}
      \verb{urlraw}
      \verb https://www.bag.admin.ch/bag/de/home/krankheiten/infektionskrankheiten-bekaempfen/antibiotikaresistenzen/wie-viele-antibiotika-verbrauchen-wir---.html
      \endverb
      \verb{url}
      \verb https://www.bag.admin.ch/bag/de/home/krankheiten/infektionskrankheiten-bekaempfen/antibiotikaresistenzen/wie-viele-antibiotika-verbrauchen-wir---.html
      \endverb
    \endentry
    \entry{arlet_molecular_1995}{article}{}
      \name{author}{7}{}{%
        {{hash=0d9c05d3bca10523027dbc44cabe9e63}{%
           family={Arlet},
           familyi={A\bibinitperiod},
           given={G.},
           giveni={G\bibinitperiod}}}%
        {{hash=ff00e36a6e212e9ab2bd725509ec038c}{%
           family={Brami},
           familyi={B\bibinitperiod},
           given={G.},
           giveni={G\bibinitperiod}}}%
        {{hash=3bac09bab462d37c49cd9563e9678feb}{%
           family={Décrè},
           familyi={D\bibinitperiod},
           given={D.},
           giveni={D\bibinitperiod}}}%
        {{hash=e6eddab40d7b5da69bd233b602ac7ef0}{%
           family={Flippo},
           familyi={F\bibinitperiod},
           given={A.},
           giveni={A\bibinitperiod}}}%
        {{hash=6b3dc9b850be831e61b9d241f37b8b87}{%
           family={Gaillot},
           familyi={G\bibinitperiod},
           given={O.},
           giveni={O\bibinitperiod}}}%
        {{hash=4c801ff1946b3e0a814096194739df14}{%
           family={Lagrange},
           familyi={L\bibinitperiod},
           given={P.\bibnamedelimi H.},
           giveni={P\bibinitperiod\bibinitdelim H\bibinitperiod}}}%
        {{hash=23f50b53ba4ded28e462341337acafca}{%
           family={Philippon},
           familyi={P\bibinitperiod},
           given={A.},
           giveni={A\bibinitperiod}}}%
      }
      \strng{namehash}{7d727239cf7d0ce02bc3543de2f05c35}
      \strng{fullhash}{e83c7622bdc5869ec898b367d0b004a2}
      \strng{bibnamehash}{7d727239cf7d0ce02bc3543de2f05c35}
      \strng{authorbibnamehash}{7d727239cf7d0ce02bc3543de2f05c35}
      \strng{authornamehash}{7d727239cf7d0ce02bc3543de2f05c35}
      \strng{authorfullhash}{e83c7622bdc5869ec898b367d0b004a2}
      \field{sortinit}{A}
      \field{sortinithash}{d77c7cdd82ff690d4c3ef13216f92f0b}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Abstract. To rapidly characterise {TEM}-derived extended-spectrum β-lactamases a fast and easy method using polymerase chain reaction-restriction fragment length}
      \field{day}{1}
      \field{issn}{0378-1097}
      \field{journaltitle}{{FEMS} Microbiology Letters}
      \field{langid}{english}
      \field{month}{12}
      \field{number}{2}
      \field{shortjournal}{{FEMS} Microbiol Lett}
      \field{title}{Molecular characterisation by {PCR}-restriction fragment length polymorphism of {TEM} β-lactamases}
      \field{urlday}{12}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{134}
      \field{year}{1995}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{203\bibrangedash 208}
      \range{pages}{6}
      \verb{doi}
      \verb 10.1111/j.1574-6968.1995.tb07938.x
      \endverb
      \verb{urlraw}
      \verb https://academic.oup.com/femsle/article/134/2-3/203/473943
      \endverb
      \verb{url}
      \verb https://academic.oup.com/femsle/article/134/2-3/203/473943
      \endverb
    \endentry
    \entry{noauthor_babraham_nodate}{online}{}
      \field{sortinit}{B}
      \field{sortinithash}{276475738cc058478c1677046f857703}
      \field{labeltitlesource}{title}
      \field{title}{Babraham Bioinformatics - Trim Galore!}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Babraham Bioinformatics - Trim Galore!:/home/ericulrich/Zotero/storage/GR3MABTK/trim_galore.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/
      \endverb
      \verb{url}
      \verb https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/
      \endverb
    \endentry
    \entry{noauthor_-lactam_2019}{inreference}{}
      \field{sortinit}{b}
      \field{sortinithash}{276475738cc058478c1677046f857703}
      \field{labeltitlesource}{title}
      \field{abstract}{beta-lactam antibiotics (beta-lactam antibiotics) are a class of antibiotic consisting of all antibiotic agents that contain a beta-lactam ring in their molecular structures. This includes penicillin derivatives (penams), cephalosporins (cephems), monobactams, and carbapenems. Most beta-lactam antibiotics work by inhibiting cell wall biosynthesis in the bacterial organism and are the most widely used group of antibiotics. Until 2003, when measured by sales, more than half of all commercially available antibiotics in use were beta-lactam compounds.Bacteria often develop resistance to beta-lactam antibiotics by synthesizing a beta-lactamase, an enzyme that attacks the beta-lactam ring. To overcome this resistance, beta-lactam antibiotics are often given with beta-lactamase inhibitors such as clavulanic acid.}
      \field{booktitle}{Wikipedia}
      \field{day}{16}
      \field{langid}{english}
      \field{month}{2}
      \field{note}{Page Version {ID}: 883614313}
      \field{title}{beta-lactam antibiotic}
      \field{urlday}{9}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{year}{2019}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \verb{file}
      \verb Snapshot:/home/ericulrich/Zotero/storage/2ANDH2MR/index.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://en.wikipedia.org/w/index.php?title=%CE%92-lactam_antibiotic&oldid=883614313
      \endverb
      \verb{url}
      \verb https://en.wikipedia.org/w/index.php?title=%CE%92-lactam_antibiotic&oldid=883614313
      \endverb
    \endentry
    \entry{beta-lactam_nodate}{online}{}
      \field{sortinit}{B}
      \field{sortinithash}{276475738cc058478c1677046f857703}
      \field{labeltitlesource}{title}
      \field{title}{Beta-Lactam Antibiotics - an overview {|} {ScienceDirect} Topics}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Beta-Lactam Antibiotics - an overview | ScienceDirect Topics:/home/ericulrich/Zotero/storage/8H26FTJV/beta-lactam-antibiotics.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.sciencedirect.com/topics/neuroscience/beta-lactam-antibiotics
      \endverb
      \verb{url}
      \verb https://www.sciencedirect.com/topics/neuroscience/beta-lactam-antibiotics
      \endverb
    \endentry
    \entry{noauthor_beta-lactam_nodate}{online}{}
      \field{sortinit}{B}
      \field{sortinithash}{276475738cc058478c1677046f857703}
      \field{labeltitlesource}{title}
      \field{title}{Beta-Lactam Ring - an overview {|} {ScienceDirect} Topics}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Beta-Lactam Ring - an overview | ScienceDirect Topics:/home/ericulrich/Zotero/storage/IDXYDUSU/beta-lactam-ring.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.sciencedirect.com/topics/chemistry/beta-lactam-ring
      \endverb
      \verb{url}
      \verb https://www.sciencedirect.com/topics/chemistry/beta-lactam-ring
      \endverb
    \endentry
    \entry{bradford_extended-spectrum_2001}{article}{}
      \name{author}{1}{}{%
        {{hash=4f9ce03489259072236c064f68bb39b9}{%
           family={Bradford},
           familyi={B\bibinitperiod},
           given={Patricia\bibnamedelima A.},
           giveni={P\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{4f9ce03489259072236c064f68bb39b9}
      \strng{fullhash}{4f9ce03489259072236c064f68bb39b9}
      \strng{bibnamehash}{4f9ce03489259072236c064f68bb39b9}
      \strng{authorbibnamehash}{4f9ce03489259072236c064f68bb39b9}
      \strng{authornamehash}{4f9ce03489259072236c064f68bb39b9}
      \strng{authorfullhash}{4f9ce03489259072236c064f68bb39b9}
      \field{sortinit}{B}
      \field{sortinithash}{276475738cc058478c1677046f857703}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{β-Lactamases continue to be the leading cause of resistance to β-lactam antibiotics among gram-negative bacteria. In recent years there has been an increased incidence and prevalence of extended-spectrum β-lactamases ({ESBLs}), enzymes ...}
      \field{journaltitle}{Clinical Microbiology Reviews}
      \field{langid}{english}
      \field{month}{10}
      \field{number}{4}
      \field{shorttitle}{Extended-Spectrum β-Lactamases in the 21st Century}
      \field{title}{Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{14}
      \field{year}{2001}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{933}
      \range{pages}{1}
      \verb{doi}
      \verb 10.1128/CMR.14.4.933-951.2001
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89009/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89009/
      \endverb
    \endentry
    \entry{cdc_biggest_2019}{online}{}
      \name{author}{1}{}{%
        {{hash=b451ae487bde3a3338f110920744afa8}{%
           family={{CDC}},
           familyi={C\bibinitperiod}}}%
      }
      \strng{namehash}{b451ae487bde3a3338f110920744afa8}
      \strng{fullhash}{b451ae487bde3a3338f110920744afa8}
      \strng{bibnamehash}{b451ae487bde3a3338f110920744afa8}
      \strng{authorbibnamehash}{b451ae487bde3a3338f110920744afa8}
      \strng{authornamehash}{b451ae487bde3a3338f110920744afa8}
      \strng{authorfullhash}{b451ae487bde3a3338f110920744afa8}
      \field{sortinit}{C}
      \field{sortinithash}{963e9d84a3da2344e8833203de5aed05}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Information and data on antibiotic resistance. Download images and graphics, find burden numbers, and learn more about these top threats.}
      \field{day}{27}
      \field{langid}{english}
      \field{month}{3}
      \field{title}{The biggest antibiotic-resistant threats in the U.S.}
      \field{titleaddon}{Centers for Disease Control and Prevention}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{year}{2019}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \verb{file}
      \verb Snapshot:/home/ericulrich/Zotero/storage/9F9NA8Q6/biggest_threats.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.cdc.gov/drugresistance/biggest_threats.html
      \endverb
      \verb{url}
      \verb https://www.cdc.gov/drugresistance/biggest_threats.html
      \endverb
    \endentry
    \entry{cock_biopython:_2009}{article}{}
      \name{author}{11}{}{%
        {{hash=1233053bd570a535b94aefb668da4464}{%
           family={Cock},
           familyi={C\bibinitperiod},
           given={Peter\bibnamedelimb J.\bibnamedelimi A.},
           giveni={P\bibinitperiod\bibinitdelim J\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
        {{hash=7fb7b4aad373590939ef53fafa9100ee}{%
           family={Antao},
           familyi={A\bibinitperiod},
           given={Tiago},
           giveni={T\bibinitperiod}}}%
        {{hash=d91aff958df37785c248f7c74ecd3b40}{%
           family={Chang},
           familyi={C\bibinitperiod},
           given={Jeffrey\bibnamedelima T.},
           giveni={J\bibinitperiod\bibinitdelim T\bibinitperiod}}}%
        {{hash=a1bc7c178fe8c419e9c6b711c9113191}{%
           family={Chapman},
           familyi={C\bibinitperiod},
           given={Brad\bibnamedelima A.},
           giveni={B\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
        {{hash=00b00fea0ac9a38fb81855218a98f64b}{%
           family={Cox},
           familyi={C\bibinitperiod},
           given={Cymon\bibnamedelima J.},
           giveni={C\bibinitperiod\bibinitdelim J\bibinitperiod}}}%
        {{hash=a7a4d6701ae045cc8da0d5693bbe5196}{%
           family={Dalke},
           familyi={D\bibinitperiod},
           given={Andrew},
           giveni={A\bibinitperiod}}}%
        {{hash=f00ae52babd12dc169b622d4986f7d8e}{%
           family={Friedberg},
           familyi={F\bibinitperiod},
           given={Iddo},
           giveni={I\bibinitperiod}}}%
        {{hash=ff236dbcdc91c0630e8b9eadbf91c436}{%
           family={Hamelryck},
           familyi={H\bibinitperiod},
           given={Thomas},
           giveni={T\bibinitperiod}}}%
        {{hash=67d980cd1b782e5d0ff6c62e731799f1}{%
           family={Kauff},
           familyi={K\bibinitperiod},
           given={Frank},
           giveni={F\bibinitperiod}}}%
        {{hash=79ff578649a7b5870e9c3c070af226b2}{%
           family={Wilczynski},
           familyi={W\bibinitperiod},
           given={Bartek},
           giveni={B\bibinitperiod}}}%
        {{hash=8bba02f3b8d077aeda45594967ea620d}{%
           family={Hoon},
           familyi={H\bibinitperiod},
           given={Michiel\bibnamedelimb J.\bibnamedelimi L.},
           giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod\bibinitdelim L\bibinitperiod},
           prefix={de},
           prefixi={d\bibinitperiod}}}%
      }
      \strng{namehash}{be5d01c92697061bb7d2a0c8023cabe6}
      \strng{fullhash}{a87099b1898d69086317113a4820b401}
      \strng{bibnamehash}{be5d01c92697061bb7d2a0c8023cabe6}
      \strng{authorbibnamehash}{be5d01c92697061bb7d2a0c8023cabe6}
      \strng{authornamehash}{be5d01c92697061bb7d2a0c8023cabe6}
      \strng{authorfullhash}{a87099b1898d69086317113a4820b401}
      \field{sortinit}{C}
      \field{sortinithash}{963e9d84a3da2344e8833203de5aed05}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{Abstract. Summary: The Biopython project is a mature open source international collaboration of volunteer developers, providing Python libraries for a wide ran}
      \field{day}{1}
      \field{issn}{1367-4803}
      \field{journaltitle}{Bioinformatics}
      \field{langid}{english}
      \field{month}{6}
      \field{number}{11}
      \field{shortjournal}{Bioinformatics}
      \field{shorttitle}{Biopython}
      \field{title}{Biopython: freely available Python tools for computational molecular biology and bioinformatics}
      \field{urlday}{16}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{25}
      \field{year}{2009}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{1422\bibrangedash 1423}
      \range{pages}{2}
      \verb{doi}
      \verb 10.1093/bioinformatics/btp163
      \endverb
      \verb{file}
      \verb Full Text PDF:/home/ericulrich/Zotero/storage/M8R7T963/Cock et al. - 2009 - Biopython freely available Python tools for compu.pdf:application/pdf;Snapshot:/home/ericulrich/Zotero/storage/V3C2GSED/330687.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://academic.oup.com/bioinformatics/article/25/11/1422/330687
      \endverb
      \verb{url}
      \verb https://academic.oup.com/bioinformatics/article/25/11/1422/330687
      \endverb
    \endentry
    \entry{noauthor_colistin:_nodate}{online}{}
      \field{sortinit}{C}
      \field{sortinithash}{963e9d84a3da2344e8833203de5aed05}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{How effective is colistin against multidrug-resistant Gram-negative pathogens?}
      \field{shorttitle}{Colistin}
      \field{title}{Colistin: An Update on the Antibiotic of the 21st Century}
      \field{titleaddon}{Medscape}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{urlraw}
      \verb http://www.medscape.com/viewarticle/772588
      \endverb
      \verb{url}
      \verb http://www.medscape.com/viewarticle/772588
      \endverb
    \endentry
    \entry{dancer_problem_2001}{article}{}
      \name{author}{1}{}{%
        {{hash=84990f64be7fd3359f5a237264e4e854}{%
           family={Dancer},
           familyi={D\bibinitperiod},
           given={S.\bibnamedelimi J.},
           giveni={S\bibinitperiod\bibinitdelim J\bibinitperiod}}}%
      }
      \strng{namehash}{84990f64be7fd3359f5a237264e4e854}
      \strng{fullhash}{84990f64be7fd3359f5a237264e4e854}
      \strng{bibnamehash}{84990f64be7fd3359f5a237264e4e854}
      \strng{authorbibnamehash}{84990f64be7fd3359f5a237264e4e854}
      \strng{authornamehash}{84990f64be7fd3359f5a237264e4e854}
      \strng{authorfullhash}{84990f64be7fd3359f5a237264e4e854}
      \field{sortinit}{D}
      \field{sortinithash}{2ef1bd9a78cc71eb74d7231c635177b8}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Abstract. The cephalosporin antibiotics have become a major part of the antibiotic formulary for hospitals in affluent countries. They are prescribed for a wid}
      \field{day}{1}
      \field{issn}{0305-7453}
      \field{journaltitle}{Journal of Antimicrobial Chemotherapy}
      \field{langid}{english}
      \field{month}{10}
      \field{number}{4}
      \field{shortjournal}{J Antimicrob Chemother}
      \field{title}{The problem with cephalosporins}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{48}
      \field{year}{2001}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{463\bibrangedash 478}
      \range{pages}{16}
      \verb{doi}
      \verb 10.1093/jac/48.4.463
      \endverb
      \verb{urlraw}
      \verb https://academic.oup.com/jac/article/48/4/463/700308
      \endverb
      \verb{url}
      \verb https://academic.oup.com/jac/article/48/4/463/700308
      \endverb
    \endentry
    \entry{ding_panx:_2018}{article}{}
      \name{author}{3}{}{%
        {{hash=9a3131ca498ba863c0c6f33fa7baac32}{%
           family={Ding},
           familyi={D\bibinitperiod},
           given={Wei},
           giveni={W\bibinitperiod}}}%
        {{hash=3af769c68fb5f0a256d02bee87292434}{%
           family={Baumdicker},
           familyi={B\bibinitperiod},
           given={Franz},
           giveni={F\bibinitperiod}}}%
        {{hash=09bb95fa57d17304a4f66e02a6114335}{%
           family={Neher},
           familyi={N\bibinitperiod},
           given={Richard\bibnamedelima A},
           giveni={R\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{0024663bee2af55926132b8fa910ca38}
      \strng{fullhash}{0024663bee2af55926132b8fa910ca38}
      \strng{bibnamehash}{0024663bee2af55926132b8fa910ca38}
      \strng{authorbibnamehash}{0024663bee2af55926132b8fa910ca38}
      \strng{authornamehash}{0024663bee2af55926132b8fa910ca38}
      \strng{authorfullhash}{0024663bee2af55926132b8fa910ca38}
      \field{sortinit}{D}
      \field{sortinithash}{2ef1bd9a78cc71eb74d7231c635177b8}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{Horizontal transfer, gene loss, and duplication result in dynamic bacterial genomes shaped by a complex mixture of different modes of evolution. Closely related strains can differ in the presence or absence of many genes, and the total number of distinct genes found in a set of related isolates—the pan-genome—is often many times larger than the genome of individual isolates. We have developed a pipeline that efficiently identifies orthologous gene clusters in the pan-genome. This pipeline is coupled to a powerful yet easy-to-use web-based visualization for interactive exploration of the pan-genome. The visualization consists of connected components that allow rapid filtering and searching of genes and inspection of their evolutionary history. For each gene cluster, {panX} displays an alignment, a phylogenetic tree, maps mutations within that cluster to the branches of the tree and infers gain and loss of genes on the core-genome phylogeny. {PanX} is available at pangenome.de. Custom pan-genomes can be visualized either using a web server or by serving {panX} locally as a browser-based application.}
      \field{day}{9}
      \field{issn}{0305-1048}
      \field{journaltitle}{Nucleic Acids Research}
      \field{month}{1}
      \field{number}{1}
      \field{shortjournal}{Nucleic Acids Res}
      \field{shorttitle}{{panX}}
      \field{title}{{panX}: pan-genome analysis and exploration}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{46}
      \field{year}{2018}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{e5}
      \range{pages}{-1}
      \verb{doi}
      \verb 10.1093/nar/gkx977
      \endverb
      \verb{file}
      \verb PubMed Central Full Text PDF:/home/ericulrich/Zotero/storage/QLPK4JC5/Ding et al. - 2018 - panX pan-genome analysis and exploration.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758898/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758898/
      \endverb
    \endentry
    \entry{doselmann_rapid_2017}{article}{}
      \name{author}{7}{}{%
        {{hash=804372be11e3de10186186d6df60434f}{%
           family={Dößelmann},
           familyi={D\bibinitperiod},
           given={Bianca},
           giveni={B\bibinitperiod}}}%
        {{hash=3c985e0349ccf97189fd114a3c973124}{%
           family={Willmann},
           familyi={W\bibinitperiod},
           given={Matthias},
           giveni={M\bibinitperiod}}}%
        {{hash=79e44aa4888178d2edd425fc1aaffba2}{%
           family={Steglich},
           familyi={S\bibinitperiod},
           given={Matthias},
           giveni={M\bibinitperiod}}}%
        {{hash=4c6a26bfc4af50428b4a4a8b3c997628}{%
           family={Bunk},
           familyi={B\bibinitperiod},
           given={Boyke},
           giveni={B\bibinitperiod}}}%
        {{hash=94e3878d0d183f49883e4dff9dc89ef0}{%
           family={Nübel},
           familyi={N\bibinitperiod},
           given={Ulrich},
           giveni={U\bibinitperiod}}}%
        {{hash=815143122b082859cdc07227274ea7c9}{%
           family={Peter},
           familyi={P\bibinitperiod},
           given={Silke},
           giveni={S\bibinitperiod}}}%
        {{hash=09bb95fa57d17304a4f66e02a6114335}{%
           family={Neher},
           familyi={N\bibinitperiod},
           given={Richard\bibnamedelima A.},
           giveni={R\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{3a963d144fd707492d81db7ec4d8da37}
      \strng{fullhash}{8d287bfbd53910b3dd16958ff54667d3}
      \strng{bibnamehash}{3a963d144fd707492d81db7ec4d8da37}
      \strng{authorbibnamehash}{3a963d144fd707492d81db7ec4d8da37}
      \strng{authornamehash}{3a963d144fd707492d81db7ec4d8da37}
      \strng{authorfullhash}{8d287bfbd53910b3dd16958ff54667d3}
      \field{sortinit}{D}
      \field{sortinithash}{2ef1bd9a78cc71eb74d7231c635177b8}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Colistin is a last-resort antibiotic commonly used against multidrug-resistant strains of Pseudomonas aeruginosa To investigate the potential for in situ evolution of resistance against colistin and to map the molecular targets of colistin resistance, we exposed two P. aeruginosa isolates to colistin using a continuous-culture device known as a morbidostat. As a result, colistin resistance reproducibly increased 10-fold within 10 days and 100-fold within 20 days, along with highly stereotypic yet strain-specific mutation patterns. The majority of mutations hit the {pmrAB} two-component signaling system and genes involved in lipopolysaccharide ({LPS}) synthesis, including {lpxC}, {pmrE}, and {migA} We tracked the frequencies of all arising mutations by whole-genome deep sequencing every 3 to 4 days to obtain a detailed picture of the dynamics of resistance evolution, including competition and displacement among multiple resistant subpopulations. In 7 out of 18 cultures, we observed mutations in {mutS} along with a mutator phenotype that seemed to facilitate resistance evolution.}
      \field{issn}{1098-6596}
      \field{journaltitle}{Antimicrobial Agents and Chemotherapy}
      \field{number}{9}
      \field{shortjournal}{Antimicrob. Agents Chemother.}
      \field{title}{Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture}
      \field{volume}{61}
      \field{year}{2017}
      \field{dateera}{ce}
      \verb{doi}
      \verb 10.1128/AAC.00043-17
      \endverb
      \keyw{Anti-Bacterial Agents,Bacterial Proteins,Colistin,colistin resistance,Drug Resistance,Multiple,Bacterial,experimental evolution,Humans,Microbial Sensitivity Tests,morbidostat,Mutation,Pseudomonas aeruginosa,Pseudomonas Infections}
    \endentry
    \entry{fair_antibiotics_2014}{article}{}
      \name{author}{2}{}{%
        {{hash=190f807aedf9ed7ff352e5bed4d7d81f}{%
           family={Fair},
           familyi={F\bibinitperiod},
           given={Richard\bibnamedelima J.},
           giveni={R\bibinitperiod\bibinitdelim J\bibinitperiod}}}%
        {{hash=d4562f17e1c3551baadcee866c4a68d8}{%
           family={Tor},
           familyi={T\bibinitperiod},
           given={Yitzhak},
           giveni={Y\bibinitperiod}}}%
      }
      \strng{namehash}{3546f55db7921c119158c71cb9883dbf}
      \strng{fullhash}{3546f55db7921c119158c71cb9883dbf}
      \strng{bibnamehash}{3546f55db7921c119158c71cb9883dbf}
      \strng{authorbibnamehash}{3546f55db7921c119158c71cb9883dbf}
      \strng{authornamehash}{3546f55db7921c119158c71cb9883dbf}
      \strng{authorfullhash}{3546f55db7921c119158c71cb9883dbf}
      \field{sortinit}{F}
      \field{sortinithash}{669c706c6f1fbf3b5a83d26f1d9e9e72}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addressed. Profiles of bacterial species that are deemed to be particularly concerning at the present time are illustrated. Factors including economic impact, intrinsic and acquired drug resistance, morbidity and mortality rates, and means of infection are taken into account. Synchronously with the waxing of bacterial resistance there has been waning antibiotic development. The approaches that scientists are employing in the pursuit of new antibacterial agents are briefly described. The standings of established antibiotic classes as well as potentially emerging classes are assessed with an emphasis on molecules that have been clinically approved or are in advanced stages of development. Historical perspectives, mechanisms of action and resistance, spectrum of activity, and preeminent members of each class are discussed.}
      \field{issn}{1177-391X}
      \field{journaltitle}{Perspectives in Medicinal Chemistry}
      \field{shortjournal}{Perspect Medicin Chem}
      \field{title}{Antibiotics and bacterial resistance in the 21st century}
      \field{volume}{6}
      \field{year}{2014}
      \field{dateera}{ce}
      \field{pages}{25\bibrangedash 64}
      \range{pages}{40}
      \verb{doi}
      \verb 10.4137/PMC.S14459
      \endverb
      \verb{file}
      \verb Full Text:/home/ericulrich/Zotero/storage/7CMUKNES/Fair and Tor - 2014 - Antibiotics and bacterial resistance in the 21st c.pdf:application/pdf
      \endverb
      \keyw{antibiotic resistance mechanisms,antibiotics,drug-resistant bacteria,novel antibiotic targets}
    \endentry
    \entry{noauthor_fast_2018}{article}{}
      \field{sortinit}{F}
      \field{sortinithash}{669c706c6f1fbf3b5a83d26f1d9e9e72}
      \field{labeltitlesource}{title}
      \field{abstract}{Das Schweizerische Zentrum für Antibiotikaresistenzen (Anresis) hat erstmals ermittelt, wie viele Menschen in der Schweiz an Infektionen durch antibiotikaresistente Bakterien sterben.}
      \field{day}{10}
      \field{issn}{0376-6829}
      \field{langid}{german}
      \field{month}{11}
      \field{title}{Fast 300 Tote durch resistente Bakterien in der Schweiz {|} {NZZ}}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{year}{2018}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \verb{file}
      \verb Snapshot:/home/ericulrich/Zotero/storage/HLJP5LJ8/fast-300-tote-durch-resistente-bakterien-in-der-schweiz-ld.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.nzz.ch/panorama/fast-300-tote-durch-resistente-bakterien-in-der-schweiz-ld.1435245
      \endverb
      \verb{url}
      \verb https://www.nzz.ch/panorama/fast-300-tote-durch-resistente-bakterien-in-der-schweiz-ld.1435245
      \endverb
    \endentry
    \entry{fernandes_-lactams:_2013}{article}{}
      \name{author}{3}{}{%
        {{hash=70c0ca8a6f914f96a82d08db8bb8c124}{%
           family={Fernandes},
           familyi={F\bibinitperiod},
           given={Rúben},
           giveni={R\bibinitperiod}}}%
        {{hash=e19f16a747311724574fc8d24ac2fdaa}{%
           family={Amador},
           familyi={A\bibinitperiod},
           given={Paula},
           giveni={P\bibinitperiod}}}%
        {{hash=f654ade7699eb0f8294597855cbfbd4d}{%
           family={Prudêncio},
           familyi={P\bibinitperiod},
           given={Cristina},
           giveni={C\bibinitperiod}}}%
      }
      \strng{namehash}{a4314af03915d13ee51a46d267c0244a}
      \strng{fullhash}{a4314af03915d13ee51a46d267c0244a}
      \strng{bibnamehash}{a4314af03915d13ee51a46d267c0244a}
      \strng{authorbibnamehash}{a4314af03915d13ee51a46d267c0244a}
      \strng{authornamehash}{a4314af03915d13ee51a46d267c0244a}
      \strng{authorfullhash}{a4314af03915d13ee51a46d267c0244a}
      \field{sortinit}{F}
      \field{sortinithash}{669c706c6f1fbf3b5a83d26f1d9e9e72}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{issn}{0954-139X}
      \field{journaltitle}{Reviews in Medical Microbiology}
      \field{langid}{english}
      \field{month}{1}
      \field{number}{1}
      \field{shorttitle}{β-Lactams}
      \field{title}{β-Lactams: chemical structure, mode of action and mechanisms of resistance}
      \field{urlday}{9}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{24}
      \field{year}{2013}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{7\bibrangedash 17}
      \range{pages}{11}
      \verb{doi}
      \verb 10.1097/MRM.0b013e3283587727
      \endverb
      \verb{urlraw}
      \verb http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00013542-201301000-00002
      \endverb
      \verb{url}
      \verb http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00013542-201301000-00002
      \endverb
    \endentry
    \entry{noauthor_fig._nodateflem}{online}{}
      \field{sortinit}{F}
      \field{sortinithash}{669c706c6f1fbf3b5a83d26f1d9e9e72}
      \field{labeltitlesource}{title}
      \field{abstract}{Download scientific diagram {|} Bacterial targets of current antibiotics used in the clinic.  from publication: Combination therapy: Synergism between natural plant extracts and antibiotics against infectious diseases {|} Antibiotics are one of the most important weapons in fighting bacterial infections and have greatly benefited the health‐related quality of human life since their introduction. However, over the past few decades these health benefits are under threat as many commonly used... {|} Plant Extracts, Antibiotics and Drug Resistance {|} {ResearchGate}, the professional network for scientists.}
      \field{langid}{english}
      \field{title}{Fig. 2 Bacterial targets of current antibiotics used in the clinic.}
      \field{titleaddon}{{ResearchGate}}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{urlraw}
      \verb https://www.researchgate.net/figure/Bacterial-targets-of-current-antibiotics-used-in-the-clinic_fig2_268064090
      \endverb
      \verb{url}
      \verb https://www.researchgate.net/figure/Bacterial-targets-of-current-antibiotics-used-in-the-clinic_fig2_268064090
      \endverb
    \endentry
    \entry{fisher_bacterial_2005}{article}{}
      \name{author}{3}{}{%
        {{hash=a96f5af084fbe971b0dc5d66324a8647}{%
           family={Fisher},
           familyi={F\bibinitperiod},
           given={Jed\bibnamedelima F.},
           giveni={J\bibinitperiod\bibinitdelim F\bibinitperiod}}}%
        {{hash=8d395a2fbe33bab7f2d32a7009456a0a}{%
           family={Meroueh},
           familyi={M\bibinitperiod},
           given={Samy\bibnamedelima O.},
           giveni={S\bibinitperiod\bibinitdelim O\bibinitperiod}}}%
        {{hash=3da471e930f014eeb363108ce5bf83fd}{%
           family={Mobashery},
           familyi={M\bibinitperiod},
           given={Shahriar},
           giveni={S\bibinitperiod}}}%
      }
      \strng{namehash}{871aa5185d8162e86135f9d1c729a466}
      \strng{fullhash}{871aa5185d8162e86135f9d1c729a466}
      \strng{bibnamehash}{871aa5185d8162e86135f9d1c729a466}
      \strng{authorbibnamehash}{871aa5185d8162e86135f9d1c729a466}
      \strng{authornamehash}{871aa5185d8162e86135f9d1c729a466}
      \strng{authorfullhash}{871aa5185d8162e86135f9d1c729a466}
      \field{sortinit}{F}
      \field{sortinithash}{669c706c6f1fbf3b5a83d26f1d9e9e72}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{day}{1}
      \field{issn}{0009-2665}
      \field{journaltitle}{Chemical Reviews}
      \field{month}{2}
      \field{number}{2}
      \field{shortjournal}{Chem. Rev.}
      \field{shorttitle}{Bacterial Resistance to beta-Lactam Antibiotics}
      \field{title}{Bacterial Resistance to beta-Lactam Antibiotics:  Compelling Opportunism, Compelling Opportunity}
      \field{urlday}{9}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{105}
      \field{year}{2005}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{395\bibrangedash 424}
      \range{pages}{30}
      \verb{doi}
      \verb 10.1021/cr030102i
      \endverb
      \verb{file}
      \verb ACS Full Text PDF w/ Links:/home/ericulrich/Zotero/storage/UVULH3IF/Fisher et al. - 2005 - Bacterial Resistance to beta-Lactam Antibiotics Com.pdf:application/pdf;ACS Full Text Snapshot:/home/ericulrich/Zotero/storage/NHA2EJTL/cr030102i.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://doi.org/10.1021/cr030102i
      \endverb
      \verb{url}
      \verb https://doi.org/10.1021/cr030102i
      \endverb
    \endentry
    \entry{graevemoore_english:_2008}{artwork}{}
      \name{author}{1}{}{%
        {{hash=8f6644aff1f51a04a447821db1a7819c}{%
           family={{Graevemoore}},
           familyi={G\bibinitperiod}}}%
      }
      \strng{namehash}{8f6644aff1f51a04a447821db1a7819c}
      \strng{fullhash}{8f6644aff1f51a04a447821db1a7819c}
      \strng{bibnamehash}{8f6644aff1f51a04a447821db1a7819c}
      \strng{authorbibnamehash}{8f6644aff1f51a04a447821db1a7819c}
      \strng{authornamehash}{8f6644aff1f51a04a447821db1a7819c}
      \strng{authorfullhash}{8f6644aff1f51a04a447821db1a7819c}
      \field{sortinit}{G}
      \field{sortinithash}{5e8d2bf9d38de41b1528bd307546008f}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{day}{20}
      \field{month}{4}
      \field{shorttitle}{English}
      \field{title}{English: Illustrates differences between Gram-positive and gram-negative bacteria}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{year}{2008}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \verb{file}
      \verb Wikimedia Snapshot:/home/ericulrich/Zotero/storage/RG4TQYNH/FileGram-Cell-wall.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://commons.wikimedia.org/wiki/File:Gram-Cell-wall.svg
      \endverb
      \verb{url}
      \verb https://commons.wikimedia.org/wiki/File:Gram-Cell-wall.svg
      \endverb
    \endentry
    \entry{noauthor_high_nodate}{online}{}
      \field{sortinit}{H}
      \field{sortinithash}{5f15a7bc777ad49ff15aa4d2831b1681}
      \field{labeltitlesource}{title}
      \field{langid}{english}
      \field{title}{High levels of antibiotic resistance found worldwide, new data shows}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Snapshot:/home/ericulrich/Zotero/storage/YMHQL2VS/29-01-2018-high-levels-of-antibiotic-resistance-found-worldwide-new-data-shows.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.who.int/news-room/detail/29-01-2018-high-levels-of-antibiotic-resistance-found-worldwide-new-data-shows
      \endverb
      \verb{url}
      \verb https://www.who.int/news-room/detail/29-01-2018-high-levels-of-antibiotic-resistance-found-worldwide-new-data-shows
      \endverb
    \endentry
    \entry{noauthor_illumina_nodate}{online}{}
      \field{sortinit}{I}
      \field{sortinithash}{320bc8fe8101b9376f9f21cd507de0e8}
      \field{labeltitlesource}{title}
      \field{title}{Illumina Library Preparation for Sequencing the {GC}-Rich Fraction of Heterogeneous Genomic {DNA}}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Illumina Library Preparation for Sequencing the GC-Rich Fraction of Heterogeneous Genomic DNA:/home/ericulrich/Zotero/storage/K4QBZTVY/PMC5808798.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808798/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808798/
      \endverb
    \endentry
    \entry{pepper}{article}{}
      \name{author}{1}{}{%
        {{hash=54e01a5530f3eb3d6e84f6da4f0679f1}{%
           family={Jong\bibnamedelimb et\bibnamedelima al.},
           familyi={J\bibinitperiod\bibinitdelim e\bibinitperiod\bibinitdelim a\bibinitperiod},
           given={Anne},
           giveni={A\bibinitperiod},
           prefix={de},
           prefixi={d\bibinitperiod}}}%
      }
      \strng{namehash}{54e01a5530f3eb3d6e84f6da4f0679f1}
      \strng{fullhash}{54e01a5530f3eb3d6e84f6da4f0679f1}
      \strng{bibnamehash}{54e01a5530f3eb3d6e84f6da4f0679f1}
      \strng{authorbibnamehash}{54e01a5530f3eb3d6e84f6da4f0679f1}
      \strng{authornamehash}{54e01a5530f3eb3d6e84f6da4f0679f1}
      \strng{authorfullhash}{54e01a5530f3eb3d6e84f6da4f0679f1}
      \field{sortinit}{J}
      \field{sortinithash}{fce5f8d0bd05e8d93f3dbe21c78897ca}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{journaltitle}{BMC Geno-s}
      \field{title}{PePPER: a webserver for prediction of prokaryote promoter elements and regulons}
      \field{year}{2011}
    \endentry
    \entry{kahlmeter_breakpoints_2008}{article}{}
      \name{author}{1}{}{%
        {{hash=7538a633457b2afe0621aefe8f361bf4}{%
           family={Kahlmeter},
           familyi={K\bibinitperiod},
           given={G.},
           giveni={G\bibinitperiod}}}%
      }
      \strng{namehash}{7538a633457b2afe0621aefe8f361bf4}
      \strng{fullhash}{7538a633457b2afe0621aefe8f361bf4}
      \strng{bibnamehash}{7538a633457b2afe0621aefe8f361bf4}
      \strng{authorbibnamehash}{7538a633457b2afe0621aefe8f361bf4}
      \strng{authornamehash}{7538a633457b2afe0621aefe8f361bf4}
      \strng{authorfullhash}{7538a633457b2afe0621aefe8f361bf4}
      \field{sortinit}{K}
      \field{sortinithash}{9fd838a31ba64d981e8f44562bd33f89}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{It has long been acknowledged that the cephalosporin breakpoints used in most European countries and the {USA} fail to detect many or most extended spectrum β-lactamases ({ESBLs}) in Enterobacteriaceae and that all {ESBLs} are clinically significant. Therefore, microbiological laboratories have undertaken not only regular cephalosporin susceptibility tests based on breakpoints, but also special tests to detect all {ESBLs}. An increasing accumulation of clinical data implies that the clinical success of third generation cephalosporin therapy is related more to the minimum inhibitory concentration ({MIC}) than to the presence or absence of an {ESBL}. However, the breakpoints must be lower than those previously recommended by many breakpoint committees. In Europe, this adjustment has been achieved by {EUCAST} (European Committee on Antimicrobial Susceptibility Testing) through the ongoing process of harmonising European breakpoints. In the {USA}, the {CLSI} recently voted to adopt similar guidelines but are waiting to implement these while revising other β-lactam breakpoints. As Enterobacteriaceae are becoming increasingly resistant, a less ‘diehard’ interpretation of the relationship among {MICs}, {ESBLs} and clinical outcome may provide therapeutic alternatives in difficult situations.}
      \field{day}{1}
      \field{issn}{1198-743X}
      \field{journaltitle}{Clinical Microbiology and Infection}
      \field{month}{1}
      \field{shortjournal}{Clinical Microbiology and Infection}
      \field{title}{Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—{EUCAST} and {CLSI} breakpoints}
      \field{urlday}{12}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{14}
      \field{year}{2008}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{169\bibrangedash 174}
      \range{pages}{6}
      \verb{doi}
      \verb 10.1111/j.1469-0691.2007.01856.x
      \endverb
      \verb{urlraw}
      \verb http://www.sciencedirect.com/science/article/pii/S1198743X14604894
      \endverb
      \verb{url}
      \verb http://www.sciencedirect.com/science/article/pii/S1198743X14604894
      \endverb
      \keyw{breakpoints,cephalosporins,{CLSI},Enterobacteriacae,{EUCAST},review}
    \endentry
    \entry{klein_reply_2018}{article}{}
      \name{author}{5}{}{%
        {{hash=e677ce6178cf7e70af225ed38093c8df}{%
           family={Klein},
           familyi={K\bibinitperiod},
           given={Eili\bibnamedelima Y.},
           giveni={E\bibinitperiod\bibinitdelim Y\bibinitperiod}}}%
        {{hash=299e7f0a9b4d3a01871d8239987aafc8}{%
           family={Tseng},
           familyi={T\bibinitperiod},
           given={Katie\bibnamedelima K.},
           giveni={K\bibinitperiod\bibinitdelim K\bibinitperiod}}}%
        {{hash=8700288be2f5e0367ad64b03843c096d}{%
           family={Levin},
           familyi={L\bibinitperiod},
           given={Simon\bibnamedelima A.},
           giveni={S\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
        {{hash=b1518a3119776336606b25ae3c2a7929}{%
           family={Goossens},
           familyi={G\bibinitperiod},
           given={Herman},
           giveni={H\bibinitperiod}}}%
        {{hash=55b6fc11a3ac803cb8010a4a21299ad3}{%
           family={Laxminarayan},
           familyi={L\bibinitperiod},
           given={Ramanan},
           giveni={R\bibinitperiod}}}%
      }
      \strng{namehash}{0b9062668f1957c25d56ddcdc74cede0}
      \strng{fullhash}{c29b69303655eeeca073e366ebd7b5aa}
      \strng{bibnamehash}{0b9062668f1957c25d56ddcdc74cede0}
      \strng{authorbibnamehash}{0b9062668f1957c25d56ddcdc74cede0}
      \strng{authornamehash}{0b9062668f1957c25d56ddcdc74cede0}
      \strng{authorfullhash}{c29b69303655eeeca073e366ebd7b5aa}
      \field{sortinit}{K}
      \field{sortinithash}{9fd838a31ba64d981e8f44562bd33f89}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{The concept of defined daily doses ({DDDs}) is rooted in the understanding that to assess drug utilization and to develop rational interventions at the patient level, a common framework for comparing varied sources and forms of drug utilization data are necessary (1⇓–3). A primary aim of the {WHO} Collaborating Centre for Drug Statistics Methodology ({WHO}-{CC}-{DSM}), which maintains {DDD} values, is to keep {DDD} values as stable as possible for the purposes of evaluating longitudinal drug utilization data. Because the {DDDs} for antibiotics have been a matter of debate for many years, the {WHO}-{CC}-{DSM} decided to implement {DDD} changes for several Anatomical Therapeutic Chemical ({ATC}) classification codes [{ATC}/{DDD} Index; e.g., amoxicillin (J01CA04) and amoxicillin/clavulanic acid (J01CR02)] starting January 1, … [↵][1]1To whom correspondence should be addressed. Email: klein\{at\}cddep.org. [1]: \#xref-corresp-1-1}
      \field{day}{4}
      \field{issn}{0027-8424, 1091-6490}
      \field{journaltitle}{Proceedings of the National Academy of Sciences}
      \field{langid}{english}
      \field{month}{12}
      \field{number}{49}
      \field{shortjournal}{{PNAS}}
      \field{shorttitle}{Reply to Charra et al.}
      \field{title}{Reply to Charra et al.: Global longitudinal assessment of 2019 changes in defined daily doses}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{115}
      \field{year}{2018}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{E11433\bibrangedash E11435}
      \range{pages}{-1}
      \verb{doi}
      \verb 10.1073/pnas.1817182115
      \endverb
      \verb{urlraw}
      \verb https://www.pnas.org/content/115/49/E11433
      \endverb
      \verb{url}
      \verb https://www.pnas.org/content/115/49/E11433
      \endverb
    \endentry
    \entry{klein_third-generation_1995}{article}{}
      \name{author}{2}{}{%
        {{hash=afce3eeb0561eeb6e2373ac098326330}{%
           family={Klein},
           familyi={K\bibinitperiod},
           given={N.\bibnamedelimi C.},
           giveni={N\bibinitperiod\bibinitdelim C\bibinitperiod}}}%
        {{hash=4440d04e67651bfc9e43556dec12b50a}{%
           family={Cunha},
           familyi={C\bibinitperiod},
           given={B.\bibnamedelimi A.},
           giveni={B\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{8dee9807541b59741793fc11e8e44239}
      \strng{fullhash}{8dee9807541b59741793fc11e8e44239}
      \strng{bibnamehash}{8dee9807541b59741793fc11e8e44239}
      \strng{authorbibnamehash}{8dee9807541b59741793fc11e8e44239}
      \strng{authornamehash}{8dee9807541b59741793fc11e8e44239}
      \strng{authorfullhash}{8dee9807541b59741793fc11e8e44239}
      \field{sortinit}{K}
      \field{sortinithash}{9fd838a31ba64d981e8f44562bd33f89}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Third-generation cephalosporins are broad-spectrum antimicrobial agents useful in a variety of clinical situations. No one cephalosporin is appropriate for all infectious disease problems. Cefotaxime and ceftizoxime have the best gram-positive coverage of the third-generation agents. Ceftazidime and cefoperazone are the only third-generation drugs that provide antipseudomonal coverage. Ceftriaxone's long half-life allows for once-daily dosing, making ceftriaxone an excellent drug for outpatient antibiotic therapy of community-acquired infections. Ceftriaxone is also useful for the treatment of Lyme disease and sexually transmitted diseases. The third-generation cephalosporins except for cefoperazone penetrate cerebrospinal fluid and are indicated for the treatment of bacterial meningitis. Their proven record of clinical efficacy, favorable pharmacokinetics, and low frequency of adverse effects make third-generation cephalosporins the preferred antibiotic in many clinical situations.}
      \field{issn}{0025-7125}
      \field{journaltitle}{The Medical Clinics of North America}
      \field{month}{7}
      \field{number}{4}
      \field{shortjournal}{Med. Clin. North Am.}
      \field{title}{Third-generation cephalosporins}
      \field{volume}{79}
      \field{year}{1995}
      \field{dateera}{ce}
      \field{pages}{705\bibrangedash 719}
      \range{pages}{15}
      \keyw{Bacterial Infections,Cephalosporins,Gram-Negative Bacteria,Gram-Positive Bacteria,Humans,Structure-Activity Relationship}
    \endentry
    \entry{kuzin_structure_1999}{article}{}
      \name{author}{6}{}{%
        {{hash=7bf2713cfcd0b548557371df8467fead}{%
           family={Kuzin},
           familyi={K\bibinitperiod},
           given={Alexandre\bibnamedelima P.},
           giveni={A\bibinitperiod\bibinitdelim P\bibinitperiod}}}%
        {{hash=9c393a0af8aae332e1e879f33d08c1d9}{%
           family={Nukaga},
           familyi={N\bibinitperiod},
           given={Michiyoshi},
           giveni={M\bibinitperiod}}}%
        {{hash=55213355f004fbef43858dbfee6b08ef}{%
           family={Nukaga},
           familyi={N\bibinitperiod},
           given={Yasuko},
           giveni={Y\bibinitperiod}}}%
        {{hash=c1804f596a26edf040628ce7a71a9b96}{%
           family={Hujer},
           familyi={H\bibinitperiod},
           given={Andrea\bibnamedelima M.},
           giveni={A\bibinitperiod\bibinitdelim M\bibinitperiod}}}%
        {{hash=1974c9e2840e02c7b4d10d3d0fdf8c4c}{%
           family={Bonomo},
           familyi={B\bibinitperiod},
           given={Robert\bibnamedelima A.},
           giveni={R\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
        {{hash=2b48dea61934df15cf4bba8028ff303e}{%
           family={Knox},
           familyi={K\bibinitperiod},
           given={James\bibnamedelima R.},
           giveni={J\bibinitperiod\bibinitdelim R\bibinitperiod}}}%
      }
      \strng{namehash}{741ec6a4f44adfa031fd2158273a8bbc}
      \strng{fullhash}{437398ccf763e271b2dc0a6e7c8daf47}
      \strng{bibnamehash}{741ec6a4f44adfa031fd2158273a8bbc}
      \strng{authorbibnamehash}{741ec6a4f44adfa031fd2158273a8bbc}
      \strng{authornamehash}{741ec6a4f44adfa031fd2158273a8bbc}
      \strng{authorfullhash}{437398ccf763e271b2dc0a6e7c8daf47}
      \field{sortinit}{K}
      \field{sortinithash}{9fd838a31ba64d981e8f44562bd33f89}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{The X-ray crystallographic structure of the {SHV}-1 β-lactamase has been established. The enzyme crystallizes from poly(ethylene glycol) at {pH} 7 in space group P212121 with cell dimensions a = 49.6 Å, b = 55.6 Å, and c = 87.0 Å. The structure was solved by the molecular replacement method, and the model has been refined to an R-factor of 0.18 for all data in the range 8.0−1.98 Å resolution. Deviations of model bonds and angles from ideal values are 0.018 Å and 1.8°, respectively. Overlay of all 263 α-carbon atoms in the {SHV}-1 and {TEM}-1 β-lactamases results in an rms deviation of 1.4 Å. Largest deviations occur in the H10 helix (residues 218−224) and in the loops between strands in the β-sheet. All atoms in residues 70, 73, 130, 132, 166, and 234 in the catalytic site of {SHV}-1 deviate only 0.23 Å (rms) from atoms in {TEM}-1. However, the width of the substrate binding cavity in {SHV}-1, as measured from the 104−105 and 130−132 loops on one side to the 235−238 β-strand on the other side, is 0.7−1.2 Å wider than in {TEM}-1. A structural analysis of the highly different affinity of {SHV}-1 and {TEM}-1 for the β-lactamase inhibitory protein {BLIP} focuses on interactions involving Asp/Glu104.}
      \field{day}{1}
      \field{issn}{0006-2960}
      \field{journaltitle}{Biochemistry}
      \field{month}{5}
      \field{number}{18}
      \field{shortjournal}{Biochemistry}
      \field{title}{Structure of the {SHV}-1 β-Lactamase}
      \field{urlday}{10}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{38}
      \field{year}{1999}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{5720\bibrangedash 5727}
      \range{pages}{8}
      \verb{doi}
      \verb 10.1021/bi990136d
      \endverb
      \verb{file}
      \verb ACS Full Text PDF w/ Links:/home/ericulrich/Zotero/storage/3E2XU7L8/Kuzin et al. - 1999 - Structure of the SHV-1 β-Lactamase.pdf:application/pdf;ACS Full Text Snapshot:/home/ericulrich/Zotero/storage/BQJNDB2J/bi990136d.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://doi.org/10.1021/bi990136d
      \endverb
      \verb{url}
      \verb https://doi.org/10.1021/bi990136d
      \endverb
    \endentry
    \entry{leclercq_eucast_2013}{article}{}
      \name{author}{14}{}{%
        {{hash=aadec25132da13f077a9b0820f4303d9}{%
           family={Leclercq},
           familyi={L\bibinitperiod},
           given={R.},
           giveni={R\bibinitperiod}}}%
        {{hash=8298bdfc8e088549cadd12d1bcd90362}{%
           family={Cantón},
           familyi={C\bibinitperiod},
           given={R.},
           giveni={R\bibinitperiod}}}%
        {{hash=d82fd009fe0607507fe7a4dbd849b046}{%
           family={Brown},
           familyi={B\bibinitperiod},
           given={D.\bibnamedelimi F.\bibnamedelimi J.},
           giveni={D\bibinitperiod\bibinitdelim F\bibinitperiod\bibinitdelim J\bibinitperiod}}}%
        {{hash=90904d655e60a276f7790122ecf9bbf2}{%
           family={Giske},
           familyi={G\bibinitperiod},
           given={C.\bibnamedelimi G.},
           giveni={C\bibinitperiod\bibinitdelim G\bibinitperiod}}}%
        {{hash=c4e1eceb6a01539e9afb2fe83319ca2e}{%
           family={Heisig},
           familyi={H\bibinitperiod},
           given={P.},
           giveni={P\bibinitperiod}}}%
        {{hash=68fe2b7b826effda4b215b59c8609783}{%
           family={{MacGowan}},
           familyi={M\bibinitperiod},
           given={A.\bibnamedelimi P.},
           giveni={A\bibinitperiod\bibinitdelim P\bibinitperiod}}}%
        {{hash=ce657fd1bc4f88e0d55183dcb52f1850}{%
           family={Mouton},
           familyi={M\bibinitperiod},
           given={J.\bibnamedelimi W.},
           giveni={J\bibinitperiod\bibinitdelim W\bibinitperiod}}}%
        {{hash=574cecd1cc55579cc2f947382f655dde}{%
           family={Nordmann},
           familyi={N\bibinitperiod},
           given={P.},
           giveni={P\bibinitperiod}}}%
        {{hash=b55d15cb5bfda389483863a073be73a4}{%
           family={Rodloff},
           familyi={R\bibinitperiod},
           given={A.\bibnamedelimi C.},
           giveni={A\bibinitperiod\bibinitdelim C\bibinitperiod}}}%
        {{hash=1c7ef46414590fcb7418b154f479c415}{%
           family={Rossolini},
           familyi={R\bibinitperiod},
           given={G.\bibnamedelimi M.},
           giveni={G\bibinitperiod\bibinitdelim M\bibinitperiod}}}%
        {{hash=f571abdcb84d213ff556e5de2594f63e}{%
           family={Soussy},
           familyi={S\bibinitperiod},
           given={C.-J.},
           giveni={C\bibinithyphendelim J\bibinitperiod}}}%
        {{hash=23ae55cc266821b0b6cfa5821af174e5}{%
           family={Steinbakk},
           familyi={S\bibinitperiod},
           given={M.},
           giveni={M\bibinitperiod}}}%
        {{hash=485ce60a628e1795dcd05d112b4cd7bb}{%
           family={Winstanley},
           familyi={W\bibinitperiod},
           given={T.\bibnamedelimi G.},
           giveni={T\bibinitperiod\bibinitdelim G\bibinitperiod}}}%
        {{hash=7538a633457b2afe0621aefe8f361bf4}{%
           family={Kahlmeter},
           familyi={K\bibinitperiod},
           given={G.},
           giveni={G\bibinitperiod}}}%
      }
      \strng{namehash}{b87e83543a5478c320d183a93d4a1a0a}
      \strng{fullhash}{503960f4a33df9cb1c8bc43bdf609e62}
      \strng{bibnamehash}{b87e83543a5478c320d183a93d4a1a0a}
      \strng{authorbibnamehash}{b87e83543a5478c320d183a93d4a1a0a}
      \strng{authornamehash}{b87e83543a5478c320d183a93d4a1a0a}
      \strng{authorfullhash}{503960f4a33df9cb1c8bc43bdf609e62}
      \field{sortinit}{L}
      \field{sortinithash}{2c7981aaabc885868aba60f0c09ee20f}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{{EUCAST} expert rules have been developed to assist clinical microbiologists and describe actions to be taken in response to specific antimicrobial susceptibility test results. They include recommendations on reporting, such as inferring susceptibility to other agents from results with one, suppression of results that may be inappropriate, and editing of results from susceptible to intermediate or resistant or from intermediate to resistant on the basis of an inferred resistance mechanism. They are based on current clinical and/or microbiological evidence. {EUCAST} expert rules also include intrinsic resistance phenotypes and exceptional resistance phenotypes, which have not yet been reported or are very rare. The applicability of {EUCAST} expert rules depends on the {MIC} breakpoints used to define the rules. Setting appropriate clinical breakpoints, based on treating patients and not on the detection of resistance mechanisms, may lead to modification of some expert rules in the future.}
      \field{issn}{1469-0691}
      \field{journaltitle}{Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases}
      \field{month}{2}
      \field{number}{2}
      \field{shortjournal}{Clin. Microbiol. Infect.}
      \field{title}{{EUCAST} expert rules in antimicrobial susceptibility testing}
      \field{volume}{19}
      \field{year}{2013}
      \field{dateera}{ce}
      \field{pages}{141\bibrangedash 160}
      \range{pages}{20}
      \verb{doi}
      \verb 10.1111/j.1469-0691.2011.03703.x
      \endverb
      \keyw{Anti-Infective Agents,Bacteria,Data Interpretation,Statistical,Europe,Humans,Microbial Sensitivity Tests}
    \endentry
    \entry{li_fast_2009}{article}{}
      \name{author}{2}{}{%
        {{hash=466d90849ccf7e74e32d338b7c35491d}{%
           family={Li},
           familyi={L\bibinitperiod},
           given={Heng},
           giveni={H\bibinitperiod}}}%
        {{hash=517afe729b2eb59735ba80628d943bb0}{%
           family={Durbin},
           familyi={D\bibinitperiod},
           given={Richard},
           giveni={R\bibinitperiod}}}%
      }
      \strng{namehash}{68b0c2c99236e02736a0ab4098e9a024}
      \strng{fullhash}{68b0c2c99236e02736a0ab4098e9a024}
      \strng{bibnamehash}{68b0c2c99236e02736a0ab4098e9a024}
      \strng{authorbibnamehash}{68b0c2c99236e02736a0ab4098e9a024}
      \strng{authornamehash}{68b0c2c99236e02736a0ab4098e9a024}
      \strng{authorfullhash}{68b0c2c99236e02736a0ab4098e9a024}
      \field{sortinit}{L}
      \field{sortinithash}{2c7981aaabc885868aba60f0c09ee20f}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{{MOTIVATION}: The enormous amount of short reads generated by the new {DNA} sequencing technologies call for the development of fast and accurate read alignment programs. A first generation of hash table-based methods has been developed, including {MAQ}, which is accurate, feature rich and fast enough to align short reads from a single individual. However, {MAQ} does not support gapped alignment for single-end reads, which makes it unsuitable for alignment of longer reads where indels may occur frequently. The speed of {MAQ} is also a concern when the alignment is scaled up to the resequencing of hundreds of individuals. {RESULTS}: We implemented Burrows-Wheeler Alignment tool ({BWA}), a new read alignment package that is based on backward search with Burrows-Wheeler Transform ({BWT}), to efficiently align short sequencing reads against a large reference sequence such as the human genome, allowing mismatches and gaps. {BWA} supports both base space reads, e.g. from Illumina sequencing machines, and color space reads from {AB} {SOLiD} machines. Evaluations on both simulated and real data suggest that {BWA} is approximately 10-20x faster than {MAQ}, while achieving similar accuracy. In addition, {BWA} outputs alignment in the new standard {SAM} (Sequence Alignment/Map) format. Variant calling and other downstream analyses after the alignment can be achieved with the open source {SAMtools} software package. {AVAILABILITY}: http://maq.sourceforge.net.}
      \field{day}{15}
      \field{issn}{1367-4811}
      \field{journaltitle}{Bioinformatics (Oxford, England)}
      \field{month}{7}
      \field{number}{14}
      \field{shortjournal}{Bioinformatics}
      \field{title}{Fast and accurate short read alignment with Burrows-Wheeler transform}
      \field{volume}{25}
      \field{year}{2009}
      \field{dateera}{ce}
      \field{pages}{1754\bibrangedash 1760}
      \range{pages}{7}
      \verb{doi}
      \verb 10.1093/bioinformatics/btp324
      \endverb
      \keyw{Algorithms,Genomics,Sequence Alignment,Sequence Analysis,{DNA},Software}
    \endentry
    \entry{noauthor_mechanism_nodate}{online}{}
      \field{sortinit}{M}
      \field{sortinithash}{cfd219b90152c06204fab207bc6c7cab}
      \field{labeltitlesource}{title}
      \field{title}{Mechanism of Action of Tetracyclines {|} Animations {|} {PharmaXChange}.info}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Mechanism of Action of Tetracyclines | Animations | PharmaXChange.info:/home/ericulrich/Zotero/storage/HCAUMIK3/mechanism-of-action-of-tetracyclines.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://pharmaxchange.info/2011/05/mechanism-of-action-of-tetracyclines/
      \endverb
      \verb{url}
      \verb https://pharmaxchange.info/2011/05/mechanism-of-action-of-tetracyclines/
      \endverb
    \endentry
    \entry{miller_mechanisms_2014}{article}{}
      \name{author}{3}{}{%
        {{hash=5e37de71275b8ddc97feff8f422036b7}{%
           family={Miller},
           familyi={M\bibinitperiod},
           given={William\bibnamedelima R},
           giveni={W\bibinitperiod\bibinitdelim R\bibinitperiod}}}%
        {{hash=0a742c96181d06fb07fc74b9f9ffad47}{%
           family={Munita},
           familyi={M\bibinitperiod},
           given={Jose\bibnamedelima M},
           giveni={J\bibinitperiod\bibinitdelim M\bibinitperiod}}}%
        {{hash=9ed08cef49f3e730ee4d68485d00748d}{%
           family={Arias},
           familyi={A\bibinitperiod},
           given={Cesar\bibnamedelima A},
           giveni={C\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{2bec1f7b735dab8a4b75da6cff8fb4b3}
      \strng{fullhash}{2bec1f7b735dab8a4b75da6cff8fb4b3}
      \strng{bibnamehash}{2bec1f7b735dab8a4b75da6cff8fb4b3}
      \strng{authorbibnamehash}{2bec1f7b735dab8a4b75da6cff8fb4b3}
      \strng{authornamehash}{2bec1f7b735dab8a4b75da6cff8fb4b3}
      \strng{authorfullhash}{2bec1f7b735dab8a4b75da6cff8fb4b3}
      \field{sortinit}{M}
      \field{sortinithash}{cfd219b90152c06204fab207bc6c7cab}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Multidrug-resistant ({MDR}) enterococci are important nosocomial pathogens and a growing clinical challenge. These organisms have developed resistance to virtually all antimicrobials currently used in clinical practice using a diverse number of genetic strategies. Due to this ability to recruit antibiotic resistance determinants, {MDR} enterococci display a wide repertoire of antibiotic resistance mechanisms including modification of drug targets, inactivation of therapeutic agents, overexpression of efflux pumps and a sophisticated cell envelope adaptive response that promotes survival in the human host and the nosocomial environment. {MDR} enterococci are well adapted to survive in the gastrointestinal tract and can become the dominant flora under antibiotic pressure, predisposing the severely ill and immunocompromised patient to invasive infections. A thorough understanding of the mechanisms underlying antibiotic resistance in enterococci is the first step for devising strategies to control the spread of these organisms and potentially establish novel therapeutic approaches.}
      \field{issn}{1478-7210}
      \field{journaltitle}{Expert review of anti-infective therapy}
      \field{month}{10}
      \field{number}{10}
      \field{shortjournal}{Expert Rev Anti Infect Ther}
      \field{title}{Mechanisms of antibiotic resistance in enterococci}
      \field{urlday}{12}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{12}
      \field{year}{2014}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{1221\bibrangedash 1236}
      \range{pages}{16}
      \verb{doi}
      \verb 10.1586/14787210.2014.956092
      \endverb
      \verb{file}
      \verb PubMed Central Full Text PDF:/home/ericulrich/Zotero/storage/CS495HER/Miller et al. - 2014 - Mechanisms of antibiotic resistance in enterococci.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433168/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433168/
      \endverb
    \endentry
    \entry{costs}{online}{}
      \field{sortinit}{M}
      \field{sortinithash}{cfd219b90152c06204fab207bc6c7cab}
      \field{labeltitlesource}{title}
      \field{langid}{english}
      \field{title}{Modelling the antibiotic development process}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{urlraw}
      \verb https://amr-review.org/sites/default/files/Modelling%20the%20antibiotic%20development%20process.pdf
      \endverb
      \verb{url}
      \verb https://amr-review.org/sites/default/files/Modelling%20the%20antibiotic%20development%20process.pdf
      \endverb
    \endentry
    \entry{munita_mechanisms_2016}{article}{}
      \name{author}{2}{}{%
        {{hash=0a742c96181d06fb07fc74b9f9ffad47}{%
           family={Munita},
           familyi={M\bibinitperiod},
           given={Jose\bibnamedelima M.},
           giveni={J\bibinitperiod\bibinitdelim M\bibinitperiod}}}%
        {{hash=9ed08cef49f3e730ee4d68485d00748d}{%
           family={Arias},
           familyi={A\bibinitperiod},
           given={Cesar\bibnamedelima A.},
           giveni={C\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{ddce9111f1c7cc94bcb962f4e8f134ef}
      \strng{fullhash}{ddce9111f1c7cc94bcb962f4e8f134ef}
      \strng{bibnamehash}{ddce9111f1c7cc94bcb962f4e8f134ef}
      \strng{authorbibnamehash}{ddce9111f1c7cc94bcb962f4e8f134ef}
      \strng{authornamehash}{ddce9111f1c7cc94bcb962f4e8f134ef}
      \strng{authorfullhash}{ddce9111f1c7cc94bcb962f4e8f134ef}
      \field{sortinit}{M}
      \field{sortinithash}{cfd219b90152c06204fab207bc6c7cab}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Emergence of resistance among the most important bacterial pathogens is recognized as a major public health threat affecting humans worldwide. Multidrug-resistant organisms have emerged not only in the hospital environment but are now often identified in community settings, suggesting that reservoirs of antibiotic-resistant bacteria are present outside the hospital. The bacterial response to the antibiotic “attack” is the prime example of bacterial adaptation and the pinnacle of evolution. “Survival of the fittest” is a consequence of an immense genetic plasticity of bacterial pathogens that trigger specific responses that result in mutational adaptations, acquisition of genetic material or alteration of gene expression producing resistance to virtually all antibiotics currently available in clinical practice. Therefore, understanding the biochemical and genetic basis of resistance is of paramount importance to design strategies to curtail the emergence and spread of resistance and devise innovative therapeutic approaches against multidrug-resistant organisms. In this chapter, we will describe in detail the major mechanisms of antibiotic resistance encountered in clinical practice providing specific examples in relevant bacterial pathogens.}
      \field{issn}{2165-0497}
      \field{journaltitle}{Microbiology spectrum}
      \field{month}{4}
      \field{number}{2}
      \field{shortjournal}{Microbiol Spectr}
      \field{title}{Mechanisms of Antibiotic Resistance}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{4}
      \field{year}{2016}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \verb{doi}
      \verb 10.1128/microbiolspec.VMBF-0016-2015
      \endverb
      \verb{file}
      \verb PubMed Central Full Text PDF:/home/ericulrich/Zotero/storage/6GCTZNQ5/Munita and Arias - 2016 - Mechanisms of Antibiotic Resistance.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888801/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888801/
      \endverb
    \endentry
    \entry{nurk_assembling_2013}{article}{}
      \name{author}{18}{}{%
        {{hash=3a4826015a3d30ffe7b858309b12019e}{%
           family={Nurk},
           familyi={N\bibinitperiod},
           given={Sergey},
           giveni={S\bibinitperiod}}}%
        {{hash=1deb0ae6cb30258df8d4c9ddd344a5e4}{%
           family={Bankevich},
           familyi={B\bibinitperiod},
           given={Anton},
           giveni={A\bibinitperiod}}}%
        {{hash=d46917439e7ca88e809783befbba0c98}{%
           family={Antipov},
           familyi={A\bibinitperiod},
           given={Dmitry},
           giveni={D\bibinitperiod}}}%
        {{hash=7c045aba8d844606f8956ab8d2cf43a9}{%
           family={Gurevich},
           familyi={G\bibinitperiod},
           given={Alexey\bibnamedelima A.},
           giveni={A\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
        {{hash=569c26d4a8fe822536a933ebdc20d1a8}{%
           family={Korobeynikov},
           familyi={K\bibinitperiod},
           given={Anton},
           giveni={A\bibinitperiod}}}%
        {{hash=eb968c13eeafe661704404d715636afc}{%
           family={Lapidus},
           familyi={L\bibinitperiod},
           given={Alla},
           giveni={A\bibinitperiod}}}%
        {{hash=b3fd12fa575e3c570fe817174aed7798}{%
           family={Prjibelski},
           familyi={P\bibinitperiod},
           given={Andrey\bibnamedelima D.},
           giveni={A\bibinitperiod\bibinitdelim D\bibinitperiod}}}%
        {{hash=9e17714cee5c358c3077417693f61a04}{%
           family={Pyshkin},
           familyi={P\bibinitperiod},
           given={Alexey},
           giveni={A\bibinitperiod}}}%
        {{hash=9fbe532b3525ec1beda3f0be11929079}{%
           family={Sirotkin},
           familyi={S\bibinitperiod},
           given={Alexander},
           giveni={A\bibinitperiod}}}%
        {{hash=c66c2aa7fd61a31503aa84bbbec41268}{%
           family={Sirotkin},
           familyi={S\bibinitperiod},
           given={Yakov},
           giveni={Y\bibinitperiod}}}%
        {{hash=0bfa6eb75ad8fd7dfd59252f03c7ddd3}{%
           family={Stepanauskas},
           familyi={S\bibinitperiod},
           given={Ramunas},
           giveni={R\bibinitperiod}}}%
        {{hash=84e2e5089bb3c5489d5c0e25fb2520a1}{%
           family={Clingenpeel},
           familyi={C\bibinitperiod},
           given={Scott\bibnamedelima R.},
           giveni={S\bibinitperiod\bibinitdelim R\bibinitperiod}}}%
        {{hash=00449b68457ad3c5300a6aa449990831}{%
           family={Woyke},
           familyi={W\bibinitperiod},
           given={Tanja},
           giveni={T\bibinitperiod}}}%
        {{hash=4c1185be58ee9cfdfc72e2d82fbd7bc6}{%
           family={{McLean}},
           familyi={M\bibinitperiod},
           given={Jeffrey\bibnamedelima S.},
           giveni={J\bibinitperiod\bibinitdelim S\bibinitperiod}}}%
        {{hash=2d1d8e42cd8bbba55289753c9032ad10}{%
           family={Lasken},
           familyi={L\bibinitperiod},
           given={Roger},
           giveni={R\bibinitperiod}}}%
        {{hash=c599f1526b9477caed9fbf91e91b3227}{%
           family={Tesler},
           familyi={T\bibinitperiod},
           given={Glenn},
           giveni={G\bibinitperiod}}}%
        {{hash=a27f23cb3893b7d3d4b4ddbe9b3b3377}{%
           family={Alekseyev},
           familyi={A\bibinitperiod},
           given={Max\bibnamedelima A.},
           giveni={M\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
        {{hash=dd2b06e11c769cef717da43a03f50670}{%
           family={Pevzner},
           familyi={P\bibinitperiod},
           given={Pavel\bibnamedelima A.},
           giveni={P\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{27523c1742ea9b582f5e5b63dba27161}
      \strng{fullhash}{40cc3e87d37f4fd7f3ffb6cbc1697dc0}
      \strng{bibnamehash}{27523c1742ea9b582f5e5b63dba27161}
      \strng{authorbibnamehash}{27523c1742ea9b582f5e5b63dba27161}
      \strng{authornamehash}{27523c1742ea9b582f5e5b63dba27161}
      \strng{authorfullhash}{40cc3e87d37f4fd7f3ffb6cbc1697dc0}
      \field{sortinit}{N}
      \field{sortinithash}{f7242c3ed3dc50029fca1be76c497c7c}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Recent advances in single-cell genomics provide an alternative to largely gene-centric metagenomics studies, enabling whole-genome sequencing of uncultivated bacteria. However, single-cell assembly projects are challenging due to (i) the highly nonuniform read coverage and (ii) a greatly elevated number of chimeric reads and read pairs. While recently developed single-cell assemblers have addressed the former challenge, methods for assembling highly chimeric reads remain poorly explored. We present algorithms for identifying chimeric edges and resolving complex bulges in de Bruijn graphs, which significantly improve single-cell assemblies. We further describe applications of the single-cell assembler {SPAdes} to a new approach for capturing and sequencing "microbial dark matter" that forms small pools of randomly selected single cells (called a mini-metagenome) and further sequences all genomes from the mini-metagenome at once. On single-cell bacterial datasets, {SPAdes} improves on the recently developed E+V-{SC} and {IDBA}-{UD} assemblers specifically designed for single-cell sequencing. For standard (cultivated monostrain) datasets, {SPAdes} also improves on A5, {ABySS}, {CLC}, {EULER}-{SR}, Ray, {SOAPdenovo}, and Velvet. Thus, recently developed single-cell assemblers not only enable single-cell sequencing, but also improve on conventional assemblers on their own turf. {SPAdes} is available for free online download under a {GPLv}2 license.}
      \field{issn}{1557-8666}
      \field{journaltitle}{Journal of Computational Biology: A Journal of Computational Molecular Cell Biology}
      \field{month}{10}
      \field{number}{10}
      \field{shortjournal}{J. Comput. Biol.}
      \field{title}{Assembling single-cell genomes and mini-metagenomes from chimeric {MDA} products}
      \field{volume}{20}
      \field{year}{2013}
      \field{dateera}{ce}
      \field{pages}{714\bibrangedash 737}
      \range{pages}{24}
      \verb{doi}
      \verb 10.1089/cmb.2013.0084
      \endverb
      \keyw{Algorithms,Base Composition,Computational Biology,Contig Mapping,{DNA},Bacterial,{DNA},Concatenated,Escherichia coli,Gene Library,Genome,Bacterial,High-Throughput Nucleotide Sequencing,Nucleic Acid Amplification Techniques,Pedobacter,Prochlorococcus,Sequence Analysis,{DNA},Single-Cell Analysis}
    \endentry
    \entry{palumbi_humans_2001}{article}{}
      \name{author}{1}{}{%
        {{hash=970e2e09b430fbb09319dc4a950e6ae8}{%
           family={Palumbi},
           familyi={P\bibinitperiod},
           given={Stephen\bibnamedelima R.},
           giveni={S\bibinitperiod\bibinitdelim R\bibinitperiod}}}%
      }
      \strng{namehash}{970e2e09b430fbb09319dc4a950e6ae8}
      \strng{fullhash}{970e2e09b430fbb09319dc4a950e6ae8}
      \strng{bibnamehash}{970e2e09b430fbb09319dc4a950e6ae8}
      \strng{authorbibnamehash}{970e2e09b430fbb09319dc4a950e6ae8}
      \strng{authornamehash}{970e2e09b430fbb09319dc4a950e6ae8}
      \strng{authorfullhash}{970e2e09b430fbb09319dc4a950e6ae8}
      \field{sortinit}{P}
      \field{sortinithash}{8d51b3d5b78d75b54308d706b9bbe285}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{In addition to altering global ecology, technology and human population growth also affect evolutionary trajectories, dramatically accelerating evolutionary change in other species, especially in commercially important, pest, and disease organisms. Such changes are apparent in antibiotic and human immunodeficiency virus ({HIV}) resistance to drugs, plant and insect resistance to pesticides, rapid changes in invasive species, life-history change in commercial fisheries, and pest adaptation to biological engineering products. This accelerated evolution costs at least \$33 billion to \$50 billion a year in the United States. Slowing and controlling arms races in disease and pest management have been successful in diverse ecological and economic systems, illustrating how applied evolutionary principles can help reduce the impact of humankind on evolution.}
      \field{day}{7}
      \field{issn}{0036-8075, 1095-9203}
      \field{journaltitle}{Science}
      \field{langid}{english}
      \field{month}{9}
      \field{number}{5536}
      \field{title}{Humans as the World's Greatest Evolutionary Force}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{293}
      \field{year}{2001}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{1786\bibrangedash 1790}
      \range{pages}{5}
      \verb{doi}
      \verb 10.1126/science.293.5536.1786
      \endverb
      \verb{file}
      \verb Full Text PDF:/home/ericulrich/Zotero/storage/9ZZLLW3F/Palumbi - 2001 - Humans as the World's Greatest Evolutionary Force.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://science.sciencemag.org/content/293/5536/1786
      \endverb
      \verb{url}
      \verb https://science.sciencemag.org/content/293/5536/1786
      \endverb
    \endentry
    \entry{peacock_mechanisms_2015}{article}{}
      \name{author}{2}{}{%
        {{hash=0235abf3fb96b1bd3d6b51733633c2d3}{%
           family={Peacock},
           familyi={P\bibinitperiod},
           given={Sharon\bibnamedelima J.},
           giveni={S\bibinitperiod\bibinitdelim J\bibinitperiod}}}%
        {{hash=68af1c00c809208febff804e45605245}{%
           family={Paterson},
           familyi={P\bibinitperiod},
           given={Gavin\bibnamedelima K.},
           giveni={G\bibinitperiod\bibinitdelim K\bibinitperiod}}}%
      }
      \strng{namehash}{4995e6e165d5f303e57daac8093b034e}
      \strng{fullhash}{4995e6e165d5f303e57daac8093b034e}
      \strng{bibnamehash}{4995e6e165d5f303e57daac8093b034e}
      \strng{authorbibnamehash}{4995e6e165d5f303e57daac8093b034e}
      \strng{authornamehash}{4995e6e165d5f303e57daac8093b034e}
      \strng{authorfullhash}{4995e6e165d5f303e57daac8093b034e}
      \field{sortinit}{P}
      \field{sortinithash}{8d51b3d5b78d75b54308d706b9bbe285}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Staphylococcus aureus is a major human and veterinary pathogen worldwide. Methicillin-resistant S. aureus ({MRSA}) poses a significant and enduring problem to the treatment of infection by such strains. Resistance is usually conferred by the acquisition of a nonnative gene encoding a penicillin-binding protein ({PBP}2a), with significantly lower affinity for β-lactams. This resistance allows cell-wall biosynthesis, the target of β-lactams, to continue even in the presence of typically inhibitory concentrations of antibiotic. {PBP}2a is encoded by the {mecA} gene, which is carried on a distinct mobile genetic element ({SCCmec}), the expression of which is controlled through a proteolytic signal transduction pathway comprising a sensor protein ({MecR}1) and a repressor ({MecI}). Many of the molecular and biochemical mechanisms underlying methicillin resistance in S. aureus have been elucidated, including regulatory events and the structure of key proteins. Here we review recent advances in this area.}
      \field{issn}{1545-4509}
      \field{journaltitle}{Annual Review of Biochemistry}
      \field{shortjournal}{Annu. Rev. Biochem.}
      \field{title}{Mechanisms of Methicillin Resistance in Staphylococcus aureus}
      \field{volume}{84}
      \field{year}{2015}
      \field{dateera}{ce}
      \field{pages}{577\bibrangedash 601}
      \range{pages}{25}
      \verb{doi}
      \verb 10.1146/annurev-biochem-060614-034516
      \endverb
      \keyw{Animals,antibiotic resistance,Bacterial Proteins,beta-Lactam Resistance,Humans,methicillin resistance,Methicillin-Resistant Staphylococcus aureus,{MRSA},penicillin-binding protein,Penicillin-Binding Proteins,Staphylococcal Infections,Staphylococcus aureus,β-lactam antibiotics}
    \endentry
    \entry{pfeiffer_systematic_2018}{article}{}
      \name{author}{7}{}{%
        {{hash=7aea67deb00597f5b684d4531e39c9a9}{%
           family={Pfeiffer},
           familyi={P\bibinitperiod},
           given={Franziska},
           giveni={F\bibinitperiod}}}%
        {{hash=da5733ac569da77668312199b6397ade}{%
           family={Gröber},
           familyi={G\bibinitperiod},
           given={Carsten},
           giveni={C\bibinitperiod}}}%
        {{hash=86567d5066a0186629d9a81ab930975f}{%
           family={Blank},
           familyi={B\bibinitperiod},
           given={Michael},
           giveni={M\bibinitperiod}}}%
        {{hash=0309bc440bae3516cf0b19ed9fefdb10}{%
           family={Händler},
           familyi={H\bibinitperiod},
           given={Kristian},
           giveni={K\bibinitperiod}}}%
        {{hash=dc02b7109bb1b0c4c5fbade63afc6f49}{%
           family={Beyer},
           familyi={B\bibinitperiod},
           given={Marc},
           giveni={M\bibinitperiod}}}%
        {{hash=eafdeafd9e376570b5dff63e7d4b63e4}{%
           family={Schultze},
           familyi={S\bibinitperiod},
           given={Joachim\bibnamedelima L.},
           giveni={J\bibinitperiod\bibinitdelim L\bibinitperiod}}}%
        {{hash=c002d935f044e4e6ba531522496c65d1}{%
           family={Mayer},
           familyi={M\bibinitperiod},
           given={Günter},
           giveni={G\bibinitperiod}}}%
      }
      \strng{namehash}{a1e300805b39a66f5f543b5d469415d6}
      \strng{fullhash}{2aff336626d038e2656bfe5c7c925f60}
      \strng{bibnamehash}{a1e300805b39a66f5f543b5d469415d6}
      \strng{authorbibnamehash}{a1e300805b39a66f5f543b5d469415d6}
      \strng{authornamehash}{a1e300805b39a66f5f543b5d469415d6}
      \strng{authorfullhash}{2aff336626d038e2656bfe5c7c925f60}
      \field{sortinit}{P}
      \field{sortinithash}{8d51b3d5b78d75b54308d706b9bbe285}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Next-generation sequencing ({NGS}) is the method of choice when large numbers of sequences have to be obtained. While the technique is widely applied, varying error rates have been observed. We analysed millions of reads obtained after sequencing of one single sequence on an Illumina sequencer. According to our analysis, the index-{PCR} for sample preparation has no effect on the observed error rate, even though {PCR} is traditionally seen as one of the major contributors to enhanced error rates in {NGS}. In addition, we observed very persistent pre-phasing effects although the base calling software corrects for these. Removal of shortened sequences abolished these effects and allowed analysis of the actual mutations. The average error rate determined was 0.24 ± 0.06\% per base and the percentage of mutated sequences was found to be 6.4 ± 1.24\%. Constant regions at the 5′- and 3′-end, e.g., primer binding sites used in in vitro selection procedures seem to have no effect on mutation rates and re-sequencing of samples obtains very reproducible results. As phasing effects and other sequencing problems vary between equipment and individual setups, we recommend evaluation of error rates and types to all {NGS}-users to improve the quality and analysis of {NGS} data.}
      \field{day}{19}
      \field{issn}{2045-2322}
      \field{journaltitle}{Scientific Reports}
      \field{month}{7}
      \field{number}{1}
      \field{title}{Systematic evaluation of error rates and causes in short samples in next-generation sequencing}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{8}
      \field{year}{2018}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{10950}
      \range{pages}{1}
      \verb{doi}
      \verb 10.1038/s41598-018-29325-6
      \endverb
      \verb{file}
      \verb Full Text PDF:/home/ericulrich/Zotero/storage/QKB7KKVW/Pfeiffer et al. - 2018 - Systematic evaluation of error rates and causes in.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://www.nature.com/articles/s41598-018-29325-6
      \endverb
      \verb{url}
      \verb https://www.nature.com/articles/s41598-018-29325-6
      \endverb
    \endentry
    \entry{europaisches_zentrum_fur_die_pravention_und_die_kontrolle_von_krankheiten_bacterial_2009}{collection}{}
      \name{editor}{1}{}{%
        {{hash=c03f320c9db702bd6ff6d181f0b7dbbc}{%
           family={Prävention\bibnamedelimb und\bibnamedelimb die\bibnamedelimb Kontrolle\bibnamedelimb von\bibnamedelima Krankheiten},
           familyi={P\bibinitperiod\bibinitdelim u\bibinitperiod\bibinitdelim d\bibinitperiod\bibinitdelim K\bibinitperiod\bibinitdelim v\bibinitperiod\bibinitdelim K\bibinitperiod},
           given={Europäisches\bibnamedelima Zentrum},
           giveni={E\bibinitperiod\bibinitdelim Z\bibinitperiod},
           prefix={für\bibnamedelima die},
           prefixi={f\bibinitperiod\bibinitdelim d\bibinitperiod}}}%
      }
      \list{location}{1}{%
        {Stockholm}%
      }
      \list{publisher}{1}{%
        {ECDC}%
      }
      \strng{namehash}{c03f320c9db702bd6ff6d181f0b7dbbc}
      \strng{fullhash}{c03f320c9db702bd6ff6d181f0b7dbbc}
      \strng{bibnamehash}{c03f320c9db702bd6ff6d181f0b7dbbc}
      \strng{editorbibnamehash}{c03f320c9db702bd6ff6d181f0b7dbbc}
      \strng{editornamehash}{c03f320c9db702bd6ff6d181f0b7dbbc}
      \strng{editorfullhash}{c03f320c9db702bd6ff6d181f0b7dbbc}
      \field{sortinit}{P}
      \field{sortinithash}{8d51b3d5b78d75b54308d706b9bbe285}
      \field{labelnamesource}{editor}
      \field{labeltitlesource}{shorttitle}
      \field{isbn}{978-92-9193-193-4}
      \field{langid}{english}
      \field{note}{{OCLC}: 756384831}
      \field{pagetotal}{42}
      \field{series}{{ECDC}/ {EMEA} joint technical report}
      \field{shorttitle}{The bacterial challenge, time to react}
      \field{title}{The bacterial challenge, time to react: a call to narrow the gap between multidrug-resistant bacteria in the {EU} and the development of new antibacterial agents}
      \field{year}{2009}
      \field{dateera}{ce}
      \verb{file}
      \verb Europäisches Zentrum für die Prävention und die Kontrolle von Krankheiten - 2009 - The bacterial challenge, time to react a call to .pdf:/home/ericulrich/Zotero/storage/B8SAMIA6/Europäisches Zentrum für die Prävention und die Kontrolle von Krankheiten - 2009 - The bacterial challenge, time to react a call to .pdf:application/pdf
      \endverb
    \endentry
    \entry{noauthor_resolving_nodate}{online}{}
      \field{sortinit}{R}
      \field{sortinithash}{da6b42bd3ab22fee61abed031ee405f7}
      \field{labeltitlesource}{title}
      \field{title}{Resolving structural diversity of Carbapenemase-producing gram-negative bacteria using single molecule sequencing {|} {bioRxiv}}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Resolving structural diversity of Carbapenemase-producing gram-negative bacteria using single molecule sequencing | bioRxiv:/home/ericulrich/Zotero/storage/REHMR94Y/456897v1.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.biorxiv.org/content/10.1101/456897v1
      \endverb
      \verb{url}
      \verb https://www.biorxiv.org/content/10.1101/456897v1
      \endverb
    \endentry
    \entry{seemann_:zap:_2019}{software}{}
      \name{author}{1}{}{%
        {{hash=818ed0b35f6ae7bf46f07c1c4f4b6ae3}{%
           family={Seemann},
           familyi={S\bibinitperiod},
           given={Torsten},
           giveni={T\bibinitperiod}}}%
      }
      \strng{namehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{fullhash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{bibnamehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{authorbibnamehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{authornamehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{authorfullhash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \field{extraname}{1}
      \field{sortinit}{S}
      \field{sortinithash}{322b1d5276f2f6c1bccdcd15920dbee6}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{day}{11}
      \field{month}{4}
      \field{note}{original-date: 2014-03-26T07:19:23Z}
      \field{title}{:zap: :aquarius: Rapid prokaryotic genome annotation: tseemann/prokka}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{year}{2019}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \verb{urlraw}
      \verb https://github.com/tseemann/prokka
      \endverb
      \verb{url}
      \verb https://github.com/tseemann/prokka
      \endverb
    \endentry
    \entry{seemann_prokka:_2014}{article}{}
      \name{author}{1}{}{%
        {{hash=818ed0b35f6ae7bf46f07c1c4f4b6ae3}{%
           family={Seemann},
           familyi={S\bibinitperiod},
           given={Torsten},
           giveni={T\bibinitperiod}}}%
      }
      \strng{namehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{fullhash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{bibnamehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{authorbibnamehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{authornamehash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \strng{authorfullhash}{818ed0b35f6ae7bf46f07c1c4f4b6ae3}
      \field{extraname}{2}
      \field{sortinit}{S}
      \field{sortinithash}{322b1d5276f2f6c1bccdcd15920dbee6}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{The multiplex capability and high yield of current day {DNA}-sequencing instruments has made bacterial whole genome sequencing a routine affair. The subsequent de novo assembly of reads into contigs has been well addressed. The final step of annotating all relevant genomic features on those contigs can be achieved slowly using existing web- and email-based systems, but these are not applicable for sensitive data or integrating into computational pipelines. Here we introduce Prokka, a command line software tool to fully annotate a draft bacterial genome in about 10 min on a typical desktop computer. It produces standards-compliant output files for further analysis or viewing in genome browsers. {AVAILABILITY} {AND} {IMPLEMENTATION}: Prokka is implemented in Perl and is freely available under an open source {GPLv}2 license from http://vicbioinformatics.com/.}
      \field{day}{15}
      \field{issn}{1367-4811}
      \field{journaltitle}{Bioinformatics (Oxford, England)}
      \field{month}{7}
      \field{number}{14}
      \field{shortjournal}{Bioinformatics}
      \field{shorttitle}{Prokka}
      \field{title}{Prokka: rapid prokaryotic genome annotation}
      \field{volume}{30}
      \field{year}{2014}
      \field{dateera}{ce}
      \field{pages}{2068\bibrangedash 2069}
      \range{pages}{2}
      \verb{doi}
      \verb 10.1093/bioinformatics/btu153
      \endverb
      \keyw{Genome,Bacterial,Genomics,Molecular Sequence Annotation,Sequence Analysis,{DNA},Software}
    \endentry
    \entry{shaikh_antibiotic_2015}{article}{}
      \name{author}{5}{}{%
        {{hash=b6551a2a4424910d869b8e45f5e28aac}{%
           family={Shaikh},
           familyi={S\bibinitperiod},
           given={Sibhghatulla},
           giveni={S\bibinitperiod}}}%
        {{hash=f58ab90b782eac07473a80289f8c4209}{%
           family={Fatima},
           familyi={F\bibinitperiod},
           given={Jamale},
           giveni={J\bibinitperiod}}}%
        {{hash=c9acc06d411b3c0577c5e95b54287ba9}{%
           family={Shakil},
           familyi={S\bibinitperiod},
           given={Shazi},
           giveni={S\bibinitperiod}}}%
        {{hash=926a40f8e7170ab5175f153a931aaa8f}{%
           family={Rizvi},
           familyi={R\bibinitperiod},
           given={Syed\bibnamedelimb Mohd.\bibnamedelimi Danish},
           giveni={S\bibinitperiod\bibinitdelim M\bibinitperiod\bibinitdelim D\bibinitperiod}}}%
        {{hash=8bbaf0fd0edee252e591475e552c003c}{%
           family={Kamal},
           familyi={K\bibinitperiod},
           given={Mohammad\bibnamedelima Amjad},
           giveni={M\bibinitperiod\bibinitdelim A\bibinitperiod}}}%
      }
      \strng{namehash}{97242e217fdff7ff1a572a16464a872d}
      \strng{fullhash}{80b6812ee2eca4d95d8821dc7d0b0da2}
      \strng{bibnamehash}{97242e217fdff7ff1a572a16464a872d}
      \strng{authorbibnamehash}{97242e217fdff7ff1a572a16464a872d}
      \strng{authornamehash}{97242e217fdff7ff1a572a16464a872d}
      \strng{authorfullhash}{80b6812ee2eca4d95d8821dc7d0b0da2}
      \field{sortinit}{S}
      \field{sortinithash}{322b1d5276f2f6c1bccdcd15920dbee6}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{Antibiotic resistance is a problem of deep scientific concern both in hospital and community settings. Rapid detection in clinical laboratories is essential for the judicious recognition of antimicrobial resistant organisms. Production of extended-spectrum β-lactamases ({ESBLs}) is a significant resistance-mechanism that impedes the antimicrobial treatment of infections caused by Enterobacteriaceae and is a serious threat to the currently available antibiotic armory. {ESBLs} are classified into several groups according to their amino acid sequence homology. Proper infection control practices and barriers are essential to prevent spread and outbreaks of {ESBL} producing bacteria. As bacteria have developed different strategies to counter the effects of antibiotics, the identification of the resistance mechanism may help in the discovery and design of new antimicrobial agents. The carbapenems are widely regarded as the drugs of choice for the treatment of severe infections caused by {ESBL}-producing Enterobacteriaceae, although comparative clinical trials are scarce. Hence, more expeditious diagnostic testing of {ESBL}-producing bacteria and the feasible modification of guidelines for community-onset bacteremia associated with different infections are prescribed.}
      \field{issn}{1319-562X}
      \field{journaltitle}{Saudi Journal of Biological Sciences}
      \field{month}{1}
      \field{number}{1}
      \field{shortjournal}{Saudi J Biol Sci}
      \field{shorttitle}{Antibiotic resistance and extended spectrum beta-lactamases}
      \field{title}{Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{22}
      \field{year}{2015}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{90\bibrangedash 101}
      \range{pages}{12}
      \verb{doi}
      \verb 10.1016/j.sjbs.2014.08.002
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281622/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281622/
      \endverb
    \endentry
    \entry{sharma_antimicrobial_2011}{article}{}
      \name{author}{1}{}{%
        {{hash=a3fd4f0ea9e0c4ee7050feb90555899e}{%
           family={Sharma},
           familyi={S\bibinitperiod},
           given={A},
           giveni={A\bibinitperiod}}}%
      }
      \strng{namehash}{a3fd4f0ea9e0c4ee7050feb90555899e}
      \strng{fullhash}{a3fd4f0ea9e0c4ee7050feb90555899e}
      \strng{bibnamehash}{a3fd4f0ea9e0c4ee7050feb90555899e}
      \strng{authorbibnamehash}{a3fd4f0ea9e0c4ee7050feb90555899e}
      \strng{authornamehash}{a3fd4f0ea9e0c4ee7050feb90555899e}
      \strng{authorfullhash}{a3fd4f0ea9e0c4ee7050feb90555899e}
      \field{sortinit}{S}
      \field{sortinithash}{322b1d5276f2f6c1bccdcd15920dbee6}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{issn}{0255-0857}
      \field{journaltitle}{Indian Journal of Medical Microbiology}
      \field{langid}{english}
      \field{number}{2}
      \field{shorttitle}{Antimicrobial resistance}
      \field{title}{Antimicrobial resistance: No action today, no cure tomorrow}
      \field{urlday}{10}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{29}
      \field{year}{2011}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{91}
      \range{pages}{1}
      \verb{doi}
      \verb 10.4103/0255-0857.81774
      \endverb
      \verb{file}
      \verb Sharma - 2011 - Antimicrobial resistance No action today, no cure.pdf:/home/ericulrich/Zotero/storage/RQ5YEMFW/Sharma - 2011 - Antimicrobial resistance No action today, no cure.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb http://www.ijmm.org/text.asp?2011/29/2/91/81774
      \endverb
      \verb{url}
      \verb http://www.ijmm.org/text.asp?2011/29/2/91/81774
      \endverb
    \endentry
    \entry{ecocyc}{online}{}
      \field{sortinit}{S}
      \field{sortinithash}{322b1d5276f2f6c1bccdcd15920dbee6}
      \field{labeltitlesource}{title}
      \field{day}{2}
      \field{month}{4}
      \field{title}{SmartTable: All promoters of E. coli K-12 substr. MG1655}
      \field{year}{2019}
      \field{dateera}{ce}
      \verb{urlraw}
      \verb https://www.bag.admin.ch/bag/de/home/krankheiten/infektionskrankheiten-bekaempfen/antibiotikaresistenzen/wie-viele-antibiotika-verbrauchen-wir---.html
      \endverb
      \verb{url}
      \verb https://www.bag.admin.ch/bag/de/home/krankheiten/infektionskrankheiten-bekaempfen/antibiotikaresistenzen/wie-viele-antibiotika-verbrauchen-wir---.html
      \endverb
    \endentry
    \entry{sovic_fast_2016}{article}{}
      \name{author}{6}{}{%
        {{hash=82b76fd581da2663c8344a72e04e6e80}{%
           family={Sović},
           familyi={S\bibinitperiod},
           given={Ivan},
           giveni={I\bibinitperiod}}}%
        {{hash=8b2f1cd83002422f8af1d8990e9ad672}{%
           family={Šikić},
           familyi={Š\bibinitperiod},
           given={Mile},
           giveni={M\bibinitperiod}}}%
        {{hash=b13d35f61f5914e56210b3a5cee8f71c}{%
           family={Wilm},
           familyi={W\bibinitperiod},
           given={Andreas},
           giveni={A\bibinitperiod}}}%
        {{hash=52ea6af73cd7c6c0fc4e85854cb2db1d}{%
           family={Fenlon},
           familyi={F\bibinitperiod},
           given={Shannon\bibnamedelima Nicole},
           giveni={S\bibinitperiod\bibinitdelim N\bibinitperiod}}}%
        {{hash=022a322754df73661a39ff34e10d957e}{%
           family={Chen},
           familyi={C\bibinitperiod},
           given={Swaine},
           giveni={S\bibinitperiod}}}%
        {{hash=1d990b496154dde78f34f94079e9db04}{%
           family={Nagarajan},
           familyi={N\bibinitperiod},
           given={Niranjan},
           giveni={N\bibinitperiod}}}%
      }
      \strng{namehash}{beaea614495afb4c111e4d3b5f2580ff}
      \strng{fullhash}{6419d91b09264d3f5ea25aeb640e9a10}
      \strng{bibnamehash}{beaea614495afb4c111e4d3b5f2580ff}
      \strng{authorbibnamehash}{beaea614495afb4c111e4d3b5f2580ff}
      \strng{authornamehash}{beaea614495afb4c111e4d3b5f2580ff}
      \strng{authorfullhash}{6419d91b09264d3f5ea25aeb640e9a10}
      \field{sortinit}{S}
      \field{sortinithash}{322b1d5276f2f6c1bccdcd15920dbee6}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Realizing the democratic promise of nanopore sequencing requires the development of new bioinformatics approaches to deal with its specific error characteristics. Here we present {GraphMap}, a mapping algorithm designed to analyse nanopore sequencing reads, which progressively refines candidate alignments to robustly handle potentially high-error rates and a fast graph traversal to align long reads with speed and high precision ({>}95\%). Evaluation on {MinION} sequencing data sets against short- and long-read mappers indicates that {GraphMap} increases mapping sensitivity by 10–80\% and maps {>}95\% of bases. {GraphMap} alignments enabled single-nucleotide variant calling on the human genome with increased sensitivity (15\%) over the next best mapper, precise detection of structural variants from length 100 bp to 4 kbp, and species and strain-specific identification of pathogens using {MinION} reads. {GraphMap} is available open source under the {MIT} license at https://github.com/isovic/graphmap.}
      \field{day}{15}
      \field{issn}{2041-1723}
      \field{journaltitle}{Nature Communications}
      \field{langid}{english}
      \field{month}{4}
      \field{title}{Fast and sensitive mapping of nanopore sequencing reads with {GraphMap}}
      \field{urlday}{16}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{7}
      \field{year}{2016}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{11307}
      \range{pages}{1}
      \verb{doi}
      \verb 10.1038/ncomms11307
      \endverb
      \verb{file}
      \verb Full Text PDF:/home/ericulrich/Zotero/storage/VWBRIK99/Sović et al. - 2016 - Fast and sensitive mapping of nanopore sequencing .pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://www.nature.com/articles/ncomms11307
      \endverb
      \verb{url}
      \verb https://www.nature.com/articles/ncomms11307
      \endverb
    \endentry
    \entry{tong_staphylococcus_2015}{article}{}
      \name{author}{5}{}{%
        {{hash=02a8c800c7d07fffa908893fb337c803}{%
           family={Tong},
           familyi={T\bibinitperiod},
           given={Steven\bibnamedelima {YC}},
           giveni={S\bibinitperiod\bibinitdelim Y\bibinitperiod}}}%
        {{hash=3afa28489c9a31cb0cf0d62e6703a19a}{%
           family={Davis},
           familyi={D\bibinitperiod},
           given={Joshua\bibnamedelima S.},
           giveni={J\bibinitperiod\bibinitdelim S\bibinitperiod}}}%
        {{hash=e8a41fdfe360e132c2d37bc0912b91eb}{%
           family={Eichenberger},
           familyi={E\bibinitperiod},
           given={Emily},
           giveni={E\bibinitperiod}}}%
        {{hash=1c48787500053e0febf941d3a382aac6}{%
           family={Holland},
           familyi={H\bibinitperiod},
           given={Thomas\bibnamedelima L.},
           giveni={T\bibinitperiod\bibinitdelim L\bibinitperiod}}}%
        {{hash=1611aff7718b22566e374b0edd319858}{%
           family={Fowler},
           familyi={F\bibinitperiod},
           given={Vance\bibnamedelima G.},
           giveni={V\bibinitperiod\bibinitdelim G\bibinitperiod}}}%
      }
      \strng{namehash}{b4e5f418a6f132c4ff2b16a1c8ddb8ae}
      \strng{fullhash}{444f08c03471bdfc9abf14594d0a0973}
      \strng{bibnamehash}{b4e5f418a6f132c4ff2b16a1c8ddb8ae}
      \strng{authorbibnamehash}{b4e5f418a6f132c4ff2b16a1c8ddb8ae}
      \strng{authornamehash}{b4e5f418a6f132c4ff2b16a1c8ddb8ae}
      \strng{authorfullhash}{444f08c03471bdfc9abf14594d0a0973}
      \field{sortinit}{T}
      \field{sortinithash}{6f7aff9db9dcfeb7f95fd5bbd2f78df9}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{journaltitle}{Clinical microbiology reviews}
      \field{number}{3}
      \field{shorttitle}{Staphylococcus aureus infections}
      \field{title}{Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management}
      \field{volume}{28}
      \field{year}{2015}
      \field{dateera}{ce}
      \field{pages}{603\bibrangedash 661}
      \range{pages}{59}
      \verb{file}
      \verb Full Text:/home/ericulrich/Zotero/storage/Z66NU5DN/Tong et al. - 2015 - Staphylococcus aureus infections epidemiology, pa.pdf:application/pdf;Snapshot:/home/ericulrich/Zotero/storage/SEHD59LS/603.html:text/html
      \endverb
    \endentry
    \entry{toprak_building_2013}{article}{}
      \name{author}{7}{}{%
        {{hash=5b9ab0bf21d1b34d62e653a980018762}{%
           family={Toprak},
           familyi={T\bibinitperiod},
           given={Erdal},
           giveni={E\bibinitperiod}}}%
        {{hash=04b4cdb978fb211d421baa5a33aa17ad}{%
           family={Veres},
           familyi={V\bibinitperiod},
           given={Adrian},
           giveni={A\bibinitperiod}}}%
        {{hash=a08044f31f3590967b45e3b1e8d68b4d}{%
           family={Yildiz},
           familyi={Y\bibinitperiod},
           given={Sadik},
           giveni={S\bibinitperiod}}}%
        {{hash=ed5418bbca3763a26df1c71a8b4f2c97}{%
           family={Pedraza},
           familyi={P\bibinitperiod},
           given={Juan\bibnamedelima M.},
           giveni={J\bibinitperiod\bibinitdelim M\bibinitperiod}}}%
        {{hash=bda6ee025412c08d23a09c1712fc670a}{%
           family={Chait},
           familyi={C\bibinitperiod},
           given={Remy},
           giveni={R\bibinitperiod}}}%
        {{hash=ca532e2cf7dfa60584c3119426157a1b}{%
           family={Paulsson},
           familyi={P\bibinitperiod},
           given={Johan},
           giveni={J\bibinitperiod}}}%
        {{hash=6bcdb0ad30a371c01267d28f47c5e5da}{%
           family={Kishony},
           familyi={K\bibinitperiod},
           given={Roy},
           giveni={R\bibinitperiod}}}%
      }
      \strng{namehash}{21aa0b6b659c6c59d1d5a7b1ced51e7a}
      \strng{fullhash}{60bdf1415e7c2f2aee74ff158637fa38}
      \strng{bibnamehash}{21aa0b6b659c6c59d1d5a7b1ced51e7a}
      \strng{authorbibnamehash}{21aa0b6b659c6c59d1d5a7b1ced51e7a}
      \strng{authornamehash}{21aa0b6b659c6c59d1d5a7b1ced51e7a}
      \strng{authorfullhash}{60bdf1415e7c2f2aee74ff158637fa38}
      \field{sortinit}{T}
      \field{sortinithash}{6f7aff9db9dcfeb7f95fd5bbd2f78df9}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{We present a protocol for building and operating an automated fluidic system for continuous culture that we call the 'morbidostat'. The morbidostat is used to follow the evolution of microbial drug resistance in real time. Instead of exposing bacteria to predetermined drug environments, the morbidostat constantly measures the growth rates of evolving microbial populations and dynamically adjusts drug concentrations inside culture vials in order to maintain a constant drug-induced inhibition. The growth rate measurements are done using an optical detection system that is based on measuring the intensity of back-scattered light from bacterial cells suspended in the liquid culture. The morbidostat can additionally be used as a chemostat or a turbidostat. The whole system can be built from readily available components within 2-3 weeks by biologists with some electronics experience or engineers familiar with basic microbiology.}
      \field{issn}{1750-2799}
      \field{journaltitle}{Nature Protocols}
      \field{month}{3}
      \field{number}{3}
      \field{shortjournal}{Nat Protoc}
      \field{shorttitle}{Building a morbidostat}
      \field{title}{Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition}
      \field{volume}{8}
      \field{year}{2013}
      \field{dateera}{ce}
      \field{pages}{555\bibrangedash 567}
      \range{pages}{13}
      \verb{doi}
      \verb 10.1038/nprot.nprot.2013.021
      \endverb
      \verb{file}
      \verb Accepted Version:/home/ericulrich/Zotero/storage/GWNV4I9F/Toprak et al. - 2013 - Building a morbidostat an automated continuous-cu.pdf:application/pdf
      \endverb
      \keyw{Anti-Bacterial Agents,Bacillus subtilis,Bacteria,Cell Culture Techniques,Drug Resistance,Bacterial,Escherichia coli,Evolution,Molecular,Microbial Sensitivity Tests}
    \endentry
    \entry{noauthor_treatment_nodate}{online}{}
      \field{sortinit}{T}
      \field{sortinithash}{6f7aff9db9dcfeb7f95fd5bbd2f78df9}
      \field{labeltitlesource}{title}
      \field{title}{Treatment of {ESBL}-producing E coli Lower Urinary Tract Infection}
      \field{urlday}{17}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Treatment of ESBL-producing E coli Lower Urinary Tract Infection:/home/ericulrich/Zotero/storage/SLZYWNBR/treatment-of-esbl-producing-e-coli-lower-urinary-tract-infection.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.pharmacytimes.com/publications/health-system-edition/2013/november2013/treatment-of-esbl-producing-e-coli-lower-urinary-tract-infection
      \endverb
      \verb{url}
      \verb https://www.pharmacytimes.com/publications/health-system-edition/2013/november2013/treatment-of-esbl-producing-e-coli-lower-urinary-tract-infection
      \endverb
    \endentry
    \entry{worldwar_resistance}{article}{}
      \name{author}{1}{}{%
        {{hash=160b7a1865af96b7fd00d1e92717c0f4}{%
           family={Ventola},
           familyi={V\bibinitperiod},
           given={C.\bibnamedelimi Lee},
           giveni={C\bibinitperiod\bibinitdelim L\bibinitperiod}}}%
      }
      \strng{namehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{fullhash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{bibnamehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{authorbibnamehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{authornamehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{authorfullhash}{160b7a1865af96b7fd00d1e92717c0f4}
      \field{extraname}{1}
      \field{sortinit}{V}
      \field{sortinithash}{75dd7385c90b2252c3ae853a80ca853b}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{journaltitle}{Pharmacy and Therapeutics}
      \field{title}{The Antibiotic Resistance Crisis}
      \field{year}{2015}
    \endentry
    \entry{ventola_antibiotic_2015}{article}{}
      \name{author}{1}{}{%
        {{hash=160b7a1865af96b7fd00d1e92717c0f4}{%
           family={Ventola},
           familyi={V\bibinitperiod},
           given={C.\bibnamedelimi Lee},
           giveni={C\bibinitperiod\bibinitdelim L\bibinitperiod}}}%
      }
      \strng{namehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{fullhash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{bibnamehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{authorbibnamehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{authornamehash}{160b7a1865af96b7fd00d1e92717c0f4}
      \strng{authorfullhash}{160b7a1865af96b7fd00d1e92717c0f4}
      \field{extraname}{2}
      \field{sortinit}{V}
      \field{sortinithash}{75dd7385c90b2252c3ae853a80ca853b}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{title}
      \field{abstract}{Decades after the first patients were treated with antibiotics, bacterial infections have again become a threat because of the rapid emergence of resistant bacteria—a crisis attributed to abuse of these medications and a lack of new drug development.}
      \field{issn}{1052-1372}
      \field{journaltitle}{Pharmacy and Therapeutics}
      \field{month}{4}
      \field{number}{4}
      \field{shortjournal}{P T}
      \field{title}{The Antibiotic Resistance Crisis}
      \field{urlday}{11}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{40}
      \field{year}{2015}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{277\bibrangedash 283}
      \range{pages}{7}
      \verb{file}
      \verb PubMed Central Full Text PDF:/home/ericulrich/Zotero/storage/NN2EYT9S/Ventola - 2015 - The Antibiotic Resistance Crisis.pdf:application/pdf
      \endverb
      \verb{urlraw}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
      \endverb
      \verb{url}
      \verb https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
      \endverb
    \endentry
    \entry{noauthor_who_nodate}{online}{}
      \field{sortinit}{W}
      \field{sortinithash}{ecb89ff85896a47dc313960773ac311d}
      \field{labeltitlesource}{title}
      \field{abstract}{{WHO} today published its first ever list of antibiotic-resistant \&quot;priority pathogens\&quot;—a catalogue of 12 families of bacteria that pose the greatest threat to human health.}
      \field{langid}{english}
      \field{title}{{WHO} publishes list of bacteria for which new antibiotics are urgently needed}
      \field{urlday}{9}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{urldateera}{ce}
      \verb{file}
      \verb Snapshot:/home/ericulrich/Zotero/storage/M4DZL7BC/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.html:text/html
      \endverb
      \verb{urlraw}
      \verb https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
      \endverb
      \verb{url}
      \verb https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
      \endverb
    \endentry
    \entry{wick_unicycler:_2017}{article}{}
      \name{author}{4}{}{%
        {{hash=9e37c24a223dcd894b1170564a38b3b2}{%
           family={Wick},
           familyi={W\bibinitperiod},
           given={Ryan\bibnamedelima R.},
           giveni={R\bibinitperiod\bibinitdelim R\bibinitperiod}}}%
        {{hash=5ec23a6f66d3987c6c3f56ffc07e39ef}{%
           family={Judd},
           familyi={J\bibinitperiod},
           given={Louise\bibnamedelima M.},
           giveni={L\bibinitperiod\bibinitdelim M\bibinitperiod}}}%
        {{hash=454059451b6c468cccc8325ba450e1cf}{%
           family={Gorrie},
           familyi={G\bibinitperiod},
           given={Claire\bibnamedelima L.},
           giveni={C\bibinitperiod\bibinitdelim L\bibinitperiod}}}%
        {{hash=2d65842681824a56d329731ec1fb1a3d}{%
           family={Holt},
           familyi={H\bibinitperiod},
           given={Kathryn\bibnamedelima E.},
           giveni={K\bibinitperiod\bibinitdelim E\bibinitperiod}}}%
      }
      \strng{namehash}{6b30efc449e8e55438771a889c014e90}
      \strng{fullhash}{e44fad158ac00415e1e196d02043eced}
      \strng{bibnamehash}{6b30efc449e8e55438771a889c014e90}
      \strng{authorbibnamehash}{6b30efc449e8e55438771a889c014e90}
      \strng{authornamehash}{6b30efc449e8e55438771a889c014e90}
      \strng{authorfullhash}{e44fad158ac00415e1e196d02043eced}
      \field{sortinit}{W}
      \field{sortinithash}{ecb89ff85896a47dc313960773ac311d}
      \field{labelnamesource}{author}
      \field{labeltitlesource}{shorttitle}
      \field{abstract}{The Illumina {DNA} sequencing platform generates accurate but short reads, which can be used to produce accurate but fragmented genome assemblies. Pacific Biosciences and Oxford Nanopore Technologies {DNA} sequencing platforms generate long reads that can produce complete genome assemblies, but the sequencing is more expensive and error-prone. There is significant interest in combining data from these complementary sequencing technologies to generate more accurate “hybrid” assemblies. However, few tools exist that truly leverage the benefits of both types of data, namely the accuracy of short reads and the structural resolving power of long reads. Here we present Unicycler, a new tool for assembling bacterial genomes from a combination of short and long reads, which produces assemblies that are accurate, complete and cost-effective. Unicycler builds an initial assembly graph from short reads using the de novo assembler {SPAdes} and then simplifies the graph using information from short and long reads. Unicycler uses a novel semi-global aligner to align long reads to the assembly graph. Tests on both synthetic and real reads show Unicycler can assemble larger contigs with fewer misassemblies than other hybrid assemblers, even when long-read depth and accuracy are low. Unicycler is open source ({GPLv}3) and available at github.com/rrwick/Unicycler.}
      \field{day}{8}
      \field{issn}{1553-7358}
      \field{journaltitle}{{PLOS} Computational Biology}
      \field{langid}{english}
      \field{month}{6}
      \field{number}{6}
      \field{shortjournal}{{PLOS} Computational Biology}
      \field{shorttitle}{Unicycler}
      \field{title}{Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads}
      \field{urlday}{15}
      \field{urlmonth}{4}
      \field{urlyear}{2019}
      \field{volume}{13}
      \field{year}{2017}
      \field{dateera}{ce}
      \field{urldateera}{ce}
      \field{pages}{e1005595}
      \range{pages}{-1}
      \verb{doi}
      \verb 10.1371/journal.pcbi.1005595
      \endverb
      \verb{urlraw}
      \verb https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005595
      \endverb
      \verb{url}
      \verb https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005595
      \endverb
      \keyw{Bacterial genomics,Chromosome pairs,Genome sequencing,Genomic libraries,Klebsiella pneumoniae,Plasmid construction,Sequence alignment,Sequence assembly tools}
    \endentry
  \enddatalist
  \missing{noauthor_fig._nodate}
  \missing{piezo_pumps}
  \missing{swiss_hospital}
  \missing{ventola_antibiotic_2015e}
\endrefsection
\endinput

